Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(X) Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended January 2, 2010
or
(  ) Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number 001-14423
PLEXUS CORP.
(Exact name of registrant as specified in charter)
     
Wisconsin   39-1344447
(State of Incorporation)   (IRS Employer Identification No.)
55 Jewelers Park Drive
Neenah, Wisconsin 54957-0156
(Address of principal executive offices)(Zip Code)
Telephone Number (920) 722-3451
(Registrant’s telephone number, including Area Code)
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ü            No ____
     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ____            No ____
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
     
Large accelerated filer ü
  Accelerated filer ____
 
   
Non-accelerated filer ____
  Smaller reporting company ____
(Do not check if a smaller reporting company)
   
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ____            No ü
As of January 29, 2010, there were 39,774,212 shares of Common Stock of the Company outstanding.

 


 

PLEXUS CORP.
TABLE OF CONTENTS
January 2, 2010
         
    3  
 
       
    3  
 
       
    3  
 
       
    4  
 
       
    5  
 
       
    6  
 
       
    18  
 
       
    18  
 
       
    19  
 
       
    20  
 
       
    21  
 
       
    22  
 
       
    24  
 
       
    26  
 
       
    27  
 
       
    27  
 
       
    27  
 
       
    28  
 
       
    29  
 
       
    29  
 
       
    29  
 
       
    29  
 
       
    30  
  EX-10.1
  EX-10.2
  EX-10.3
  EX-10.4
  EX-31.1
  EX-31.2
  EX-32.1
  EX-32.2

2


Table of Contents

PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME

(in thousands, except per share data)
Unaudited
                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Net sales
  $ 430,399     $ 456,109  
Cost of sales (Note 11)
    385,858       409,559  
 
               
 
               
Gross profit
    44,541       46,550  
 
               
Operating expenses:
               
Selling and administrative expenses
    24,319       25,269  
Restructuring costs
    -       550  
 
               
 
    24,319       25,819  
 
               
 
               
Operating income
    20,222       20,731  
 
               
Other income (expense):
               
Interest expense
    (2,559 )     (2,930 )
Interest income
    456       931  
Miscellaneous
    (95 )     198  
 
               
 
               
Income before income taxes
    18,024       18,930  
 
               
Income tax expense
    180       1,892  
 
               
 
               
Net income
  $ 17,844     $ 17,038  
 
               
 
               
Earnings per share:
               
Basic
  $ 0.45     $ 0.43  
 
               
Diluted
  $ 0.44     $ 0.43  
 
               
 
               
Weighted average shares outstanding:
               
Basic
    39,587       39,337  
 
               
Diluted
    40,252       39,472  
 
               
 
               
Comprehensive income:
               
Net income
  $ 17,844     $ 17,038  
Derivative instrument fair market value adjustment - net of income tax
    699       (4,518 )
Foreign currency translation adjustments
    (255 )     (4,050 )
 
               
Comprehensive income
  $ 18,288     $ 8,470  
 
               
See notes to condensed consolidated financial statements.

3


Table of Contents

PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
Unaudited
                 
    January 2,   October 3,
    2010   2009
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 233,931     $ 258,382  
Accounts receivable, net of allowances of $1,400 and $1,000, respectively
    233,904       193,222  
Inventories
    372,753       322,352  
Deferred income taxes
    14,955       15,057  
Prepaid expenses and other
    10,704       9,421  
 
               
 
               
Total current assets
    866,247       798,434  
 
               
Property, plant and equipment, net
    205,843       197,469  
 
               
Deferred income taxes
    10,209       10,305  
Other
    16,692       16,464  
 
               
 
               
Total assets
  $ 1,098,991     $ 1,022,672  
 
               
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities:
               
Current portion of long-term debt and capital lease obligations
  $ 21,626     $ 16,907  
Accounts payable
    290,498       233,061  
Customer deposits
    25,831       28,180  
Accrued liabilities:
               
Salaries and wages
    28,371       28,169  
Other
    35,758       33,004  
 
               
 
               
Total current liabilities
    402,084       339,321  
 
               
Long-term debt and capital lease obligations, net of current portion
    125,908       133,936  
Other liabilities
    21,381       21,969  
 
               
Total non-current liabilities
    147,289       155,905  
 
               
Commitments and contingencies (Note 12)
    -       -  
 
               
Shareholders’ equity:
               
Preferred stock, $.01 par value, 5,000 shares authorized, none issued or outstanding
    -       -  
Common stock, $.01 par value, 200,000 shares authorized, 47,095 and 46,994 shares issued, respectively, and 39,649 and 39,548 shares outstanding, respectively
    471       470  
Additional paid-in capital
    370,254       366,371  
Common stock held in treasury, at cost, 7,446 shares for both periods
    (200,110 )     (200,110 )
Retained earnings
    373,879       356,035  
Accumulated other comprehensive income
    5,124       4,680  
 
               
 
               
 
    549,618       527,446  
 
               
 
               
Total liabilities and shareholders’ equity
  $ 1,098,991     $ 1,022,672  
 
               
See notes to condensed consolidated financial statements.

4


Table of Contents

PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Unaudited
                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Cash flows from operating activities
               
Net income
  $ 17,844     $ 17,038  
Adjustments to reconcile net income to cash flows from operating activities:
               
Depreciation and amortization
    9,054       8,101  
(Gain) loss on sale of property, plant and equipment
    (5 )     10  
Deferred income taxes
    (1,029 )     (930 )
Stock based compensation expense
    1,839       2,810  
Changes in assets and liabilities:
               
Accounts receivable
    (40,531 )     26,253  
Inventories
    (50,253 )     (7,688 )
Prepaid expenses and other
    (1,507 )     925  
Accounts payable
    52,160       11,005  
Customer deposits
    (2,374 )     2,129  
Accrued liabilities and other
    4,537       (10,300 )
 
               
 
               
Cash flows (used in) provided by operating activities
    (10,265 )     49,353  
 
               
 
               
Cash flows from investing activities
               
Payments for property, plant and equipment
    (12,315 )     (23,494 )
Proceeds from sales of property, plant and equipment
    11       66  
 
               
 
               
Cash flows used in investing activities
    (12,304 )     (23,428 )
 
               
 
               
Cash flows from financing activities
               
Payments on debt and capital lease obligations
    (4,194 )     (7,888 )
Proceeds from exercise of stock options
    1,870       480  
Income tax benefit of stock option exercises
    175       11  
 
               
 
               
Cash flows used in financing activities
    (2,149 )     (7,397 )
 
               
 
               
Effect of foreign currency translation on cash and cash equivalents
    267       (6,107 )
 
               
 
               
Net (decrease) increase in cash and cash equivalents
    (24,451 )     12,421  
 
               
Cash and cash equivalents:
               
Beginning of period
    258,382       165,970  
 
               
End of period
  $ 233,931     $ 178,391  
 
               
See notes to condensed consolidated financial statements.

5


Table of Contents

PLEXUS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED JANUARY 2, 2010 AND JANUARY 3, 2009
UNAUDITED
NOTE 1 — BASIS OF PRESENTATION AND ACCOUNTING POLICIES
Basis of Presentation
     The condensed consolidated financial statements included herein have been prepared by Plexus Corp. and its subsidiaries (“Plexus” or the “Company”) without audit and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”). In the opinion of the Company, the condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments necessary for the fair statement of the consolidated financial position of the Company as of January 2, 2010, and the results of operations for the three months ended January 2, 2010 and January 3, 2009, and the cash flows for the same three month periods.
     Certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted pursuant to the SEC rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the condensed consolidated financial statements included herein are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s 2009 Annual Report on Form 10-K.
     The Company’s fiscal year ends on the Saturday closest to September 30. The Company also uses a “4-4-5” weekly accounting system for the interim periods in each quarter. Each quarter therefore ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. Fiscal 2009 included this additional week and the fiscal year-end was October 3, 2009. Therefore the accounting year for 2009 included 371 days. The additional week was added to the first fiscal quarter, ended January 3, 2009, which included 98 days. The accounting period for the three months ended January 2, 2010 included 91 days.
Fair Value of Financial Instruments
     The Company holds financial instruments consisting of cash and cash equivalents, accounts receivable, accounts payable, debt, and capital lease obligations. The carrying value of cash and cash equivalents, accounts receivable, accounts payable and capital lease obligations as reported in the consolidated financial statements approximates fair value. Accounts receivable were reflected at net realizable value based on anticipated losses due to potentially uncollectible balances. Anticipated losses were based on management’s analysis of historical losses and changes in customers’ credit status. The fair value of the Company’s term loan debt was $104.7 million and $107.8 million as of January 2, 2010 and October 3, 2009, respectively. The Company uses quoted market prices when available or discounted cash flows to calculate the fair values.
Subsequent Events
     In preparing the accompanying condensed consolidated financial statements, the Company has reviewed, as deemed necessary by the Company’s management, other events and transactions occurring after the balance sheet date of January 2, 2010 through February 4, 2010, which is the date that the financial statements are issued.

6


Table of Contents

NOTE 2 — INVENTORIES
     Inventories are stated at the lower of cost (on a first-in, first-out basis) or market value. The stated cost is comprised of direct materials, labor, and overhead. The major classes of inventories, net of applicable lower of cost or market write-downs, were as follows (in thousands):
                      
    January 2,   October 3,
    2010   2009
Raw materials
  $      276,884     $      237,717  
Work-in-process
    35,073       29,399  
Finished goods
    60,796       55,236  
 
               
 
  $ 372,753     $ 322,352  
 
               
     Per contractual terms, customer deposits are received by the Company to offset obsolete and excess inventory risks and are shown as part of current liabilities on the Condensed Consolidated Balance Sheets.
NOTE 3 — PROPERTY, PLANT AND EQUIPMENT
     Property, plant and equipment consisted of the following categories (in thousands):
                      
    January 2,   October 3,
    2010   2009
Land, buildings and improvements
  $ 121,019     $ 120,505  
Machinery and equipment
    227,733       220,402  
Computer hardware and software
    73,551       72,782  
Construction in progress
    20,050       11,727  
 
               
 
    442,353       425,416  
Less: accumulated depreciation and amortization
    (236,510 )     (227,947 )
 
               
 
  $      205,843     $      197,469  
 
               
NOTE 4 — LONG-TERM DEBT
     On April 4, 2008, the Company entered into a new credit agreement (the “Credit Facility”) with a group of banks which allows the Company to borrow $150 million in term loans and $100 million in revolving loans. The $150 million in term loans was immediately funded and the $100 million revolving credit facility is currently available. The Credit Facility is unsecured and the revolving credit facility may be increased by an additional $100 million (the “accordion feature”) if the Company has not previously terminated all or any portion of the Credit Facility, there is no event of default existing under the Credit Facility and both the Company and the administrative agent consent to the increase. The Credit Facility expires on April 4, 2013. Borrowings under the Credit Facility may be either through term loans or revolving or swing loans or letter of credit obligations. As of January 2, 2010, the Company has term loan borrowings of $123.8 million outstanding and no revolving borrowings under the Credit Facility.
     The Credit Facility contains certain financial covenants, which include a maximum total leverage ratio, maximum value of fixed rentals and operating lease obligations, a minimum interest coverage ratio and a minimum net worth test, all as defined in the agreement. As of January 2, 2010, the Company was in compliance with all debt covenants. If the Company incurs an event of default, as defined in the Credit Facility (including any failure to comply with a financial covenant), the group of banks has the right to terminate the remaining Credit Facility and all other obligations, and demand immediate repayment of all outstanding sums (principal and accrued interest). Interest on borrowing varies depending upon the Company’s then-current total leverage ratio; as of January 2, 2010, the Company could elect to pay interest at a defined base rate or the LIBOR rate plus 1.25%. Rates would increase upon negative changes in specified Company financial metrics and would decrease upon reduction in the current total leverage ratio to no less than LIBOR plus 1.00%. The Company is also required to pay an annual commitment fee on the unused credit commitment based on its leverage ratio; the current fee is 0.30 percent. Unless the accordion feature is exercised, this fee applies only to the initial $100 million of availability (excluding the $150 million of term borrowings). Origination fees and expenses associated with the Credit Facility totaled approximately $1.3 million and have been deferred. These origination fees and expenses are being amortized over the five-year term of the Credit Facility. Equal quarterly principal repayments of the term loan of $3.75 million per quarter began June 30, 2008 and end on April 4, 2013 with a balloon repayment of $75.0 million.

7


Table of Contents

     The Credit Facility allows for the future payment of cash dividends or the future repurchases of shares provided that no event of default (including any failure to comply with a financial covenant) is existing at the time of, or would be caused by, a dividend payment or a share repurchase.
     Interest expense related to the commitment fee and amortization of deferred origination fees and expenses for the Credit Facility totaled approximately $0.2 million for both the three months ended January 2, 2010 and January 3, 2009.
NOTE 5 — DERIVATIVES AND FAIR VALUE MEASUREMENTS
     All derivatives are recognized in the Condensed Consolidated Balance Sheets at their estimated fair value. On the date a derivative contract is entered into, the Company designates the derivative as a hedge of a recognized asset or liability (a “fair value” hedge), a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (a “cash flow” hedge), or a hedge of the net investment in a foreign operation. The Company currently has cash flow hedges related to variable rate debt and foreign currency obligations. The Company does not enter into derivatives for speculative purposes. Changes in the fair value of the derivatives that qualify as cash flow hedges are recorded in “Accumulated other comprehensive income” in the Condensed Consolidated Balance Sheets until earnings are affected by the variability of the cash flows.
     In June 2008, the Company entered into three interest rate swap contracts related to the $150 million in term loans under the Credit Facility that have a total notional value of $150 million and mature on April 4, 2013. These interest rate swap contracts will pay the Company variable interest at the three month LIBOR rate, and the Company will pay the counterparties a fixed interest rate. The fixed interest rates for each of these contracts are 4.415%, 4.490% and 4.435%, respectively. These interest rate swap contracts were entered into to convert $150 million of the variable rate term loan under the Credit Facility into fixed rate debt. Based on the terms of the interest rate swap contracts and the underlying debt, these interest rate contracts were determined to be effective, and thus qualify as a cash flow hedge. As such, any changes in the fair value of these interest rate swaps are recorded in “Accumulated other comprehensive income” on the Condensed Consolidated Balance Sheets until earnings are affected by the variability of cash flows. The total fair value of these interest rate swap contracts was $8.0 million as of January 2, 2010, and the Company has recorded this in “Other” current liabilities and “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets. As of January 2, 2010, the total combined notional amount of the Company’s three interest rate swaps was $123.8 million.
     Our Malaysian operations have entered into forward exchange contracts maturing in fiscal 2010 and 2011 with a total notional value of $30.6 million. These forward contracts will fix the exchange rates on foreign currency cash used to pay a portion of local currency expenses. The changes in the fair value of the forward contracts are recorded in “Accumulated other comprehensive income” on the accompanying Condensed Consolidated Balance Sheets until earnings are affected by the variability of cash flows. The total fair value of the forward contracts was $0.7 million at January 2, 2010, and the Company recorded this amount in “Prepaid expenses and other” in the accompanying Condensed Consolidated Balance Sheets.

8


Table of Contents

     The tables below present information regarding the fair values of derivative instruments and the effects of derivative instruments on the Company’s Statements of Operations:
                                                                                               
 
  Fair Values of Derivative Instruments    
  In thousands of dollars    
        Asset Derivatives                 Liability Derivatives    
        January 2,       October 3,                 January 2,       October 3,    
        2010       2009                 2010       2009    
  Derivatives designated     Balance                 Balance                           Balance                 Balance            
  as hedging instruments     Sheet       Fair       Sheet       Fair                 Sheet       Fair       Sheet       Fair    
      Location       Value       Location       Value                 Location       Value       Location       Value    
 
Interest rate swaps
              -                 -                 Current
liabilities - Other
    $ 1,774       Current
liabilities - Other
    $ 2,072    
 
Interest rate swaps
              -                 -                 Other liabilities     $ 6,208       Other liabilities     $ 7,253    
 
Forward contracts
     Prepaid expenses and other      $ 689       Prepaid expenses and other      $ 530                                              
 

9


Table of Contents

                                                                                               
 
  The Effect of Derivative Instruments on the Statements of Operations

   
  for the Three Months Ended    
  In thousands of dollars    
        Amount of Gain or                                               Location of Gain or       Amount of Gain or (Loss)    
        (Loss) Recognized in       Location of Gain or     Amount of Gain or                 (Loss) Recognized in       Recognized in Income on    
        Other Comprehensive       (Loss) Reclassified from     (Loss) Reclassified from                 Income on Derivative       Derivative (Ineffective    
  Derivatives in Cash     Income (“OCI”) on       Accumulated OCI into     Accumulated OCI into                 (Ineffective Portion and       Portion and Amount    
  Flow Hedging     Derivative (Effective       Income (Effective     Income (Effective                 Amount Excluded from       Excluded from    
  Relationships     Portion)       Portion)     Portion)                 Effectiveness Testing)       Effectiveness Testing)    
        January 2,     January 3,                 January 2,     January 3,                           January 2,     January 3,    
        2010     2009                 2010     2009                           2010     2009    
 
Interest rate swaps
    $ 47     $ -       Interest income (expense)     $ (1,296)     $ -                 Other income (expense)     $ -     $ -    
 
Forward contracts
    $ 316     $ -       Selling and administrative expenses     $ 157     $ -                 Other income (expense)     $ -     $ -    
 

10


Table of Contents

     The Company adopted a newly issued accounting statement on September 28, 2008, for fair value measurements of financial assets and liabilities. The Company adopted this statement for non-financial assets and liabilities on October 4, 2009. This accounting statement defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting statement established a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:
     Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.
     Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
     Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.
     The following table lists the fair values of our financial instruments as of January 2, 2010, by input level as defined above:
                                             
 
       
Fair Value Measurements Using Input Levels: (in thousands)

 
        Level 1

    Level 2

    Level 3

    Total

 
 
Derivatives
                                         
 
Interest rate swap
    $ -       $ 7,982       $ -       $ 7,982    
 
Foreign currency forward contract
    $ -       $ 689       $ -       $ 689    
 
     The Company also has $2.0 million of auction rate securities. The fair value of these securities is determined based on Level 3 inputs. There has been no material change in the fair value of these securities since October 3, 2009.

11


Table of Contents

NOTE 6 — EARNINGS PER SHARE
     The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share (in thousands, except per share amounts):
                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Basic and Diluted Earnings Per Share:
               
Net income
  $   17,844     $   17,038  
 
               
 
               
Basic weighted average common shares outstanding
    39,587       39,337  
Dilutive effect of stock options
    665       135  
 
               
Diluted weighted average shares outstanding
    40,252       39,472  
 
               
 
               
Earnings per share:
               
Basic
  $ 0.45     $ 0.43  
 
               
Diluted
  $ 0.44     $ 0.43  
 
               
     For the three months ended January 2, 2010 and January 3, 2009, stock options and stock-settled stock appreciation rights (“SARs”) to purchase approximately 1.4 million and 2.7 million shares, respectively, were outstanding but were not included in the computation of diluted earnings per share because the options’ and SARs’ exercise prices were greater than the average market price of the common shares and, therefore, their effect would be antidilutive.
NOTE 7 — STOCK-BASED COMPENSATION
     The Company recognized $1.8 million and $2.8 million of compensation expense associated with stock-based awards for the three months ended January 2, 2010 and January 3, 2009, respectively.
     The Company continues to use the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights and recognizes the stock-based compensation expense over the stock-based awards’ vesting period. The Company uses the fair value at the date of grant to value restricted stock units.
NOTE 8 — INCOME TAXES
     Income taxes for the three months ended January 2, 2010 and January 3, 2009 were $0.2 million and $1.9 million, respectively. The effective tax rates for the three months ended January 2, 2010 and January 3, 2009 were 1 percent and 10 percent, respectively. The decrease in the effective tax rate for the current year period compared to the prior year period was primarily due to an increase in the proportion of the Company’s projected fiscal 2010 pre-tax income in Malaysia and China, where the Company benefits from tax holidays.
     As of January 2, 2010, there was no material change in the amount of unrecognized tax benefits recorded for uncertain tax positions. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. The amount of interest and penalties recorded for the three months ended January 2, 2010 and January 3, 2009 was not material.
     It is reasonably possible that a number of uncertain tax positions related to federal and state tax positions may be settled within the next 12 months. Settlement of these matters is not expected to have a material effect on the Company’s consolidated results of operations, financial position and cash flows.

12


Table of Contents

NOTE 9 — BUSINESS SEGMENT, GEOGRAPHIC AND MAJOR CUSTOMER INFORMATION
     Reportable segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or group, in assessing performance and allocating resources.
     The Company uses an internal management reporting system, which provides important financial data to evaluate performance and allocate the Company’s resources on a geographic basis. Net sales for segments are attributed to the region in which the product is manufactured or service is performed. The services provided, manufacturing processes used, class of customers serviced and order fulfillment processes used are similar and generally interchangeable across the segments. A segment’s performance is evaluated based upon its operating income (loss). A segment’s operating income (loss) includes its net sales less cost of sales and selling and administrative expenses, but excludes corporate and other costs, interest expense, other income (loss), and income taxes. Corporate and other costs primarily represent corporate selling and administrative expenses, and restructuring and impairment costs. These costs are not allocated to the segments, as management excludes such costs when assessing the performance of the segments. Inter-segment transactions are generally recorded at amounts that approximate arm’s length transactions. The accounting policies for the regions are the same as for the Company taken as a whole.
     Information about the Company’s four reportable segments for the three months ended January 2, 2010 and January 3, 2009 were as follows (in thousands):
                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Net sales:
               
United States
  $   258,849     $   294,702  
Asia
    193,126       160,071  
Europe
    13,863       12,608  
Mexico
    18,595       21,752  
Elimination of inter-segment sales
    (54,034 )     (33,024 )
 
               
 
  $ 430,399     $ 456,109  
 
               
 
               
Depreciation and amortization:
               
United States
  $ 2,663     $ 2,456  
Asia
    4,378       3,610  
Europe
    222       192  
Mexico
    571       559  
Corporate
    1,220       1,284  
 
               
 
  $ 9,054     $ 8,101  
 
               
 
               
Operating income (loss):
               
United States
  $ 20,576     $ 21,733  
Asia
    23,306       18,187  
Europe
    (1,187 )     1,017  
Mexico
    (1,073 )     (722 )
Corporate and other costs
    (21,400 )     (19,484 )
 
               
 
  $ 20,222     $ 20,731  
 
               

13


Table of Contents

                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Capital expenditures:
               
United States
  $    2,994     $    5,089  
Asia
    5,010       8,403  
Europe
    194       194  
Mexico
    580       411  
Corporate
    3,537       9,397  
 
               
 
  $    12,315     $    23,494  
 
               
                 
    January 2,   October 3,
    2010   2009
Total assets:
               
United States
  $ 392,471     $ 346,272  
Asia
    426,065       370,247  
Europe
    82,816       86,024  
Mexico
    47,020       45,699  
Corporate
    150,619       174,430  
 
               
 
  $   1,098,991     $   1,022,672  
 
               
     The following enterprise-wide information is provided in accordance with the required segment disclosures. Net sales to unaffiliated customers were based on the Company’s location providing product or services (in thousands):
                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Net sales:
               
United States
  $ 258,849     $ 294,702  
Malaysia
    170,150       135,285  
China
    22,976       24,786  
United Kingdom
    13,782       12,608  
Mexico
    18,595       21,752  
Romania
    81       -  
Elimination of inter-segment sales
    (54,034 )     (33,024 )
 
               
 
  $    430,399     $    456,109  
 
               
                 
    January 2,   October 3,
    2010   2009
Long-lived assets:
               
United States
  $ 59,362     $ 51,811  
Malaysia
    74,167       72,325  
China
    15,577       14,266  
United Kingdom
    7,102       5,989  
Mexico
    6,951       6,940  
Romania
    4,416       5,760  
Corporate
    38,268       40,378  
 
               
 
  $ 205,843     $ 197,469  
 
               
     Long-lived assets as of January 2, 2010, and October 3, 2009, exclude other long-term assets totaling $26.9 million and $26.8 million, respectively.

14


Table of Contents

     Restructuring and impairment costs are not allocated to reportable segments, as management excludes such costs when assessing the performance of the reportable segments. Such costs are included within the “Corporate and other costs” section in the above operating income (loss) table. For the three months ended January 2, 2010, the Company did not incur any restructuring costs. For the three months ended January 3, 2009, the Company incurred $0.6 million of restructuring costs related to severance at the Juarez, Mexico (“Juarez”) facility.
     The percentages of net sales to customers representing 10 percent or more of total net sales for the indicated periods were as follows:
                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Juniper Networks, Inc. (“Juniper”)
    17 %     18 %
     No other customers accounted for 10 percent or more of net sales in either period.
NOTE 10 — GUARANTEES
     The Company offers certain indemnifications under its customer manufacturing agreements. In the normal course of business, the Company may from time to time be obligated to indemnify its customers or its customers’ customers against damages or liabilities arising out of the Company’s negligence, misconduct, breach of contract, or infringement of third party intellectual property rights. Certain agreements have extended broader indemnification, and while most agreements have contractual limits, some do not. However, the Company generally does not provide for such indemnities, and seeks indemnification from its customers for damages or liabilities arising out of the Company’s adherence to customers’ specifications or designs or use of materials furnished, or directed to be used, by its customers. The Company does not believe its obligations under such indemnities are material.
     In the normal course of business, the Company also provides its customers a limited warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranty generally provides that products will be free from defects in the Company’s workmanship and meet mutually agreed-upon specifications for periods generally ranging from 12 months to 24 months. If a product fails to comply with the Company’s limited warranty, the Company’s obligation is generally limited to correcting, at its expense, any defect by repairing or replacing such defective product. The Company’s warranty generally excludes defects resulting from faulty customer-supplied components, design defects or damage caused by any party or cause other than the Company.
     The Company provides for an estimate of costs that may be incurred under its limited warranty at the time product revenue is recognized and establishes additional reserves for specifically identified product issues. These costs primarily include labor and materials, as necessary, associated with repair or replacement and are included in our Condensed Consolidated Balance Sheets in other current accrued liabilities. The primary factors that affect the Company’s warranty liability include the value and the number of shipped units and historical and anticipated rates of warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.
     Below is a table summarizing the activity related to the Company’s limited warranty liability for fiscal 2009 and for the three months ended January 2, 2010 (in thousands):
         
Limited warranty liability, as of September 27, 2008
     4,052  
Accruals for warranties issued during the period
    507  
Settlements (in cash or in kind) during the period
    (89 )
 
       
Limited warranty liability, as of October 3, 2009
    4,470  
Accruals for warranties issued during the period
    267  
Settlements (in cash or in kind) during the period
    (13 )
 
       
Limited warranty liability, as of January 2, 2010
     4,724  
 
       

15


Table of Contents

NOTE 11 — LITIGATION
     In December 2009, the Company received settlement funds of approximately $3.2 million related to a court case in which the Company was a plaintiff. The settlement related to prior purchases of inventory and therefore was recorded in cost of sales.
     The Company is party to certain other lawsuits in the ordinary course of business. Management does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.
NOTE 12 — CONTINGENCIES
     We were notified in April 2009 by U.S. Customs and Border Protection (“CBP”) of its intention to conduct a customary Focused Assessment of our import activities during fiscal 2008 and of our processes and procedures to comply with U.S. Customs laws and regulations. As a result of discussions with CBP, Plexus has committed to CBP that it will report any errors, and tender any associated duties and fees relating to import trade activity, by June 2010. Plexus has also agreed that it will implement improved processes and procedures in areas where errors are found and review these corrective measures with CBP. At this time, we do not believe that any deficiencies in processes or controls, or unanticipated costs, unpaid duties or penalties associated with this matter will have a material adverse effect on Plexus or our results of operations.
NOTE 13 — RESTRUCTURING COSTS
      Fiscal 2010 restructuring costs: For the three months ended January 2, 2010, the Company did not incur any restructuring costs.
      Fiscal 2009 restructuring costs: For the three months ended January 3, 2009, the Company incurred restructuring costs of $0.6 million related to the reduction of our workforce in Juarez. The workforce reduction affected approximately 280 employees.
     The table below summarizes the Company’s accrued restructuring and impairment liabilities as of January 2, 2010 (in thousands):
                                 
    Employee   Lease        
    Termination   Obligations and   Non-cash    
    and Severance   Other Exit   Asset    
    Costs   Costs   Impairments   Total
Accrued balance, September 27, 2008
     2,038     -     -     2,038  
Restructuring and impairment costs
    2,196       876       5,748       8,820  
Adjustments to provisions
    (249 )     -       -       (249 )
Amounts utilized
       (3,941 )        (790 )        (5,748 )        (10,479 )
 
                               
Accrued balance, October 3, 2009
    44       86       -       130  
Amounts utilized
    (44 )     (86 )     -       (130 )
 
                               
Accrued balance, January 2, 2010
  -     -     -     -  
 
                               

16


Table of Contents

NOTE 14 — NEW ACCOUNTING PRONOUNCEMENTS
     In October 2009, the Financial Accounting Standards Board (“FASB”) issued a new accounting standard for Multiple-Deliverable Revenue Arrangements, which establishes a selling price hierarchy for determining the selling price of a deliverable, replaces the term “fair value” in the revenue allocation guidance with “selling price,” eliminates the residual method of allocation by requiring that arrangement consideration be allocated at the inception of the arrangement to all deliverables using the relative selling price method and requires that a vendor determine its best estimate of selling price in a manner that is consistent with that used to determine the price to sell the deliverable on a standalone basis. This guidance is effective for financial statements issued for fiscal years beginning after June 15, 2010. The Company is currently assessing the impact of this new standard on the consolidated financial statements.
     In June 2009, the FASB also issued an amendment to the accounting and disclosure requirements for the consolidation of variable interest entities (“VIEs”). The elimination of the concept of a qualifying special-purpose entity (“QSPE”) removes the exception from applying the consolidation guidance within this amendment. This amendment requires an enterprise to perform a qualitative analysis when determining whether or not it must consolidate a VIE. The amendment also requires an enterprise to continuously reassess whether it must consolidate a VIE. Additionally, the amendment requires enhanced disclosures about an enterprise’s involvement with VIEs and any significant change in risk exposure due to that involvement, as well as how its involvement with VIEs impacts the enterprise’s financial statements. Finally, an enterprise will be required to disclose significant judgments and assumptions used to determine whether or not to consolidate a VIE. This amendment is effective for financial statements issued for fiscal years beginning after November 15, 2009. The Company is currently assessing the impact of this amendment on its consolidated results of operations, financial position and cash flows.
     In June 2008, the FASB issued new accounting guidance that specifies that unvested share-based awards containing non-forfeitable rights to dividends or dividend equivalents are participating securities and should be included in the computation of earnings per share pursuant to the two-class method. The Company adopted this guidance beginning October 4, 2009, and the adoption did not have a material effect on the weighted average shares outstanding or earnings per share amounts.
     In March 2008, the FASB ratified accounting guidance for lessee maintenance deposits under lease arrangements. The guidance requires that all nonrefundable maintenance deposits be accounted for as a deposit, and expensed or capitalized when underlying maintenance is performed. If it is determined that an amount on deposit is not probable of being used to fund future maintenance, it is to be recognized as expense at the time such determination is made. The Company adopted this guidance beginning October 4, 2009, and the adoption did not have a material effect on our financial position, results of operations, or cash flows.
     In December 2007, the FASB issued authoritative guidance regarding business combinations (whether full, partial or step acquisitions) which will result in all assets and liabilities of an acquired business being recorded at their fair values. Certain forms of contingent consideration and certain acquired contingencies will be recorded at fair value at the acquisition date. The guidance also states that acquisition costs will generally be expensed as incurred and restructuring costs will be expensed in periods after the acquisition date. The Company adopted the new guidance beginning October 4, 2009, and the adoption did not have a material effect on our financial position, results of operations, or cash flows.
     In September 2006, the FASB issued new accounting guidance that defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. It also establishes a fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability. We adopted this guidance for financial assets and liabilities effective September 28, 2008, and for non-financial assets and liabilities effective October 4, 2009. Non-financial assets and liabilities subject to this new guidance primarily include goodwill and indefinite lived intangible assets measured at fair value for impairment assessments, long-lived assets measured at fair value for impairment assessments, and non-financial assets and liabilities measured at fair value in business combinations. The adoption of the new accounting guidance effective October 4, 2009, did not have a material effect on our financial position, results of operations, or cash flows.

17


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
“SAFE HARBOR” CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995:
     The statements contained in this Form 10-Q that are not historical facts (such as statements in the future tense and statements including “believe,” “expect,” “intend,” “plan,” “anticipate,” “goal,” “target” and similar terms and concepts, including all discussions of periods which are not yet completed) are forward-looking statements that involve risks and uncertainties, including, but not limited to:
    the economic performance of the industries, sectors and customers we serve
 
    the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs
 
    the poor visibility of future orders, particularly in view of current economic conditions
 
    the effects of the volume of revenue from certain sectors or programs on our margins in particular periods
 
    our ability to secure new customers, maintain our current customer base and deliver product on a timely basis
 
    the risk that our revenue and/or profits associated with customers who have recently been acquired by third parties will be negatively affected
 
    the risks relative to new customers, which risks include customer delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements and the lack of a track record of order volume and timing. These risks exist with any significant new customer program and include our recently announced arrangements with The Coca-Cola Company.
 
    the risks of concentration of work for certain customers
 
    our ability to manage successfully a complex business model
 
    the risk that new program wins and/or customer demand may not result in the expected revenue or profitability
 
    the fact that customer orders may not lead to long-term relationships
 
    the weakness of the global economy and the continuing instability of the global financial markets and banking systems, including the potential inability on our part or that of our customers or suppliers to access cash investments and credit facilities
 
    material cost fluctuations and the adequate availability of components and related parts for production, particularly due to sudden increases in customer demand
 
    the effect of changes in the pricing and margins of products
 
    the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by customers, resulting in an inventory write-off
 
    the effect of start-up costs of new programs and facilities, including our recent and planned expansions, such as our new facilities in Hangzhou, China and Oradea, Romania
 
    the adequacy of restructuring and similar charges as compared to actual expenses
 
    the risk of unanticipated costs, unpaid duties and penalties related to an ongoing audit of our import compliance by U.S. Customs and Border Protection
 
    possible unexpected costs and operating disruption in transitioning programs
 
    the potential effect of world or local events or other events outside our control (such as epidemics, drug cartel-related violence in Juarez, Mexico, changes in oil prices, terrorism and war in the Middle East)
 
    the impact of increased competition and
 
    other risks detailed herein, as well as in our Securities and Exchange Commission filings (particularly in Part I, Item 1A of our annual report on Form 10-K for the year ended October 3, 2009).

18


Table of Contents

OVERVIEW
     The following information should be read in conjunction with our condensed consolidated financial statements included herein and the “Risk Factors” section in Part I, Item 1A of our annual report on Form 10-K for the year ended October 3, 2009.
     Plexus Corp. and its subsidiaries (together “Plexus,” the “Company,” or “we”) participate in the Electronic Manufacturing Services (“EMS”) industry. We provide product realization services to original equipment manufacturers (“OEMs”) and other technology companies in the wireline/networking, wireless infrastructure, medical, industrial/commercial and defense/security/aerospace market sectors. We provide advanced product design, manufacturing and testing services to our customers with a focus on the mid-to-lower-volume, higher-mix segment of the EMS market. Our customers’ products typically require exceptional production and supply-chain flexibility, necessitating an optimized demand-pull-based manufacturing and supply chain solution across an integrated global platform. Many of our customers’ products require complex configuration management and direct order fulfillment to their customers across the globe. In such cases we provide global logistics management and after-market service and repair. Our customers’ products may have stringent requirements for quality, reliability and regulatory compliance. We offer our customers the ability to outsource all phases of product realization, including product specifications; development, design and design validation; regulatory compliance support; prototyping and new product introduction; manufacturing test equipment development; materials sourcing, procurement and supply-chain management; product assembly/manufacturing, configuration and test; order fulfillment, logistics and service/repair.
     Plexus is passionate about its goal to be the best EMS company in the world at providing services for customers that have mid-to-lower-volume requirements and a higher mix of products. We have tailored our engineering services, manufacturing operations, supply-chain management, workforce, business intelligence systems, financial goals and metrics specifically to support these types of programs. Our flexible manufacturing facilities and processes are designed to accommodate customers with multiple product-lines and configurations as well as unique quality and regulatory requirements. Each of these customers is supported by a multi-disciplinary customer team and one or more uniquely configured “focus factories” supported by a supply-chain and logistics solution specifically designed to meet the flexibility and responsiveness required to support that customer’s fulfillment requirements.
     Our go-to-market strategy is also tailored to our target market sectors and business strategy. We have business development and customer management teams that are dedicated to each of the five sectors we serve. These teams are accountable for understanding the sector participants, technology, unique quality and regulatory requirements and longer-term trends. Further, these teams help set our strategy for growth in their sectors with a particular focus on expanding the services and value-add that we provide to our current customers while strategically targeting select new customers to add to our portfolio.
     Our financial model is aligned with our business strategy, with our primary focus to earn a return on invested capital (“ROIC”) in excess of our weighted average cost of capital (“WACC”). The smaller volumes, flexibility requirements and fulfillment needs of our customers typically result in greater investments in inventory than many of our competitors, particularly those that provide EMS services for high-volume, less complex products with less stringent requirements (such as consumer electronics). In addition, our cost structure relative to these peers includes higher investments in selling and administrative costs as a percentage of sales to support our sector-based go-to-market strategy, smaller program sizes, flexibility, and complex quality and regulatory compliance requirements. By exercising discipline to generate a ROIC in excess of our WACC, our goal is to ensure that Plexus creates a value proposition for our shareholders as well as our customers.
     Our customers include both industry-leading OEMs and other technology companies that have never manufactured products internally. As a result of our focus on serving market sectors that rely on advanced electronics technology, our business is influenced by technological trends such as the level and rate of development of telecommunications infrastructure, the expansion of networks and use of the Internet. In addition, the federal Food and Drug Administration’s approval of new medical devices, defense procurement practices and other governmental approval and regulatory processes can affect our business. Our business has also benefited from the trend to increased outsourcing by OEMs.

19


Table of Contents

     We provide most of our contract manufacturing services on a turnkey basis, which means that we procure some or all of the materials required for product assembly. We provide some services on a consignment basis, which means that the customer supplies the necessary materials, and we provide the labor and other services required for product assembly. Turnkey services require material procurement and warehousing, in addition to manufacturing, and involve greater resource investments than consignment services. Other than certain test equipment and software used for internal operations, we do not design or manufacture our own proprietary products.
EXECUTIVE SUMMARY
     As a consequence of the Company’s use of a “4-4-5” weekly accounting system, periodically an additional week must be added to the fiscal year to re-align with a fiscal year end at the Saturday closest to September 30. In fiscal 2009, this required an additional week, which was added to the first fiscal quarter. Therefore, the comparisons between the first quarters of fiscal 2010 and fiscal 2009 reflect that the first quarter of fiscal 2010 included 91 days while the first quarter in fiscal 2009 included 98 days.
      Three months ended January 2, 2010. Net sales for the three months ended January 2, 2010 decreased by $25.7 million, or 5.6 percent, as compared to the three months ended January 3, 2009, to $430.4 million. The net sales decline in the current year period was driven primarily by decreased end market demand, resulting in decreased demand from numerous existing customers. In particular, decreases resulted from weakened demand from two customers in the medical sector, and for a defense customer due to the inability of this customer to secure additional orders for the product we formerly manufactured.
     Gross margins were 10.3 percent for the three months ended January 2, 2010, which compared favorably to 10.2 percent for the three months ended January 3, 2009. Gross margins in the current year period improved as a result of $3.2 million of proceeds received from a litigation settlement, which provided a benefit of 0.7 percentage points. Without this settlement, gross margins decreased as a result of reduced net sales and changes in customer mix.
     Selling and administrative expenses for the three months ended January 2, 2010 were $24.3 million, a decrease of $1.0 million, or 3.8 percent, over the three months ended January 3, 2009. The current year period included a decrease in stock-based compensation expense, headcount reductions and continued cost containment, partially offset by higher variable incentive compensation expense.
     Net income for the three months ended January 2, 2010 increased to $17.8 million, or 4.7 percent, from $17.0 million for the three months ended January 3, 2009, and diluted earnings per share increased to $0.44 in the current year period from $0.43 in the prior year period. Net income increased from the prior year period due to higher gross margins and lower selling and administrative expenses, as described above, as well as a lower effective tax rate in the current year period. The effective tax rate in the current year period was 1 percent versus a 10 percent effective tax rate in the prior year period. The decrease in the effective tax rate from the prior year period was primarily due to an increase in the proportion of our projected fiscal 2010 pre-tax income in Malaysia and China (where we currently benefit from reduced rates due to tax holidays) when compared to fiscal 2009 pre-tax income.
      Fiscal 2010 outlook. Our financial goals for fiscal 2010 are to capitalize on the ramp of new business wins and signs of improvement in the economy and customer demand to drive increases in our operating income, which we believe will return our ROIC above our estimated WACC.
     We currently expect net sales in the second quarter of fiscal 2010 to be in the range of $470 million to $495 million; however, our results will ultimately depend upon the actual level of customer orders and production. We are currently in a period of parts shortages for some components, based on lack of capacity at some of our suppliers to meet increased demand from the gradually improving economic outlook. We believe we have sufficient parts availability to support the revenue guidance for the second quarter of fiscal 2010 and are managing this issue aggressively to support revenue in future quarters. Assuming that net sales are in the range noted above, we would currently expect to earn, before any restructuring and impairment costs, between $0.44 to $0.52 per diluted share in the second quarter of fiscal 2010.
     We currently expect the annual effective tax rate for fiscal 2010 to be in the low single digits.

20


Table of Contents

REPORTABLE SEGMENTS
     A further discussion of financial performance by reportable segment is presented below (dollars in millions):
                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Net sales:
               
United States
  $ 258.9     $ 294.7  
Asia
    193.1       160.1  
Europe
    13.9       12.6  
Mexico
    18.6       21.7  
Elimination of inter-segment sales
    (54.1 )     (33.0 )
 
               
 
  $ 430.4     $ 456.1  
 
               
                 
    Three Months Ended
    January 2,   January 3,
    2010   2009
Operating income (loss):
               
United States
  $ 20.6     $ 21.7  
Asia
    23.3       18.2  
Europe
    (1.2 )     1.0  
Mexico
    (1.1 )     (0.7 )
Corporate and other costs
    (21.4 )     (19.5 )
 
               
 
  $ 20.2     $ 20.7  
 
               
    United States: Net sales for the current year period decreased primarily due to reduced demand from our largest customer, Juniper Networks, Inc. (“Juniper”), and a defense customer, partially offset by demand from a customer in the wireless infrastructure sector. Net sales to Juniper decreased over the prior year period due to the transfer of manufacturing of some products to our Asia reportable segment and as a result of decreased demand from their end-market. In addition, our net sales to a defense customer decreased over the prior year period due to the inability of that customer to secure additional orders for the product we formerly manufactured. Operating income for the current year period decreased primarily as a result of lower revenues from the customers noted above and changes in customer mix, particularly related to the defense customer, offset by proceeds received from a litigation settlement.
 
    Asia: Net sales growth for the current year period reflected increased net sales from the transfer of manufacturing of some Juniper products from the United States reportable segment to the Asia reportable segment, as well as increased demand from a customer in the wireless/infrastructure sector. Operating income in the current year period improved as a result of the net sales growth.
 
    Europe: Net sales in the current year period increased due primarily to increased demand from a customer program in the industrial/commercial sector, offset by reduced demand from a medical sector customer. The operating loss in the current year period, as compared to operating income in the prior year period, resulted from changes in customer mix.
 
    Mexico: Net sales for the current year period decreased due primarily to decreased demand from a customer in the industrial/commercial sector, as well as the cessation of two customer programs, partially offset by demand from a new customer program in the industrial/commercial sector. Operating loss for the current year period increased slightly due to reduced net sales volume in the current year period.

21


Table of Contents

     For our significant customers, we generally manufacture product in more than one location. Net sales to Juniper, our largest customer, occur in the United States and Asia. See Note 9 in Notes to Condensed Consolidated Financial Statements for certain financial information regarding our reportable segments, including a detail of net sales by reportable segment.
RESULTS OF OPERATIONS
      Net sales. Net sales for the indicated periods were as follows (dollars in millions):
                               
    Three months ended    
    January 2,   January 3,   Increase /
    2010   2009   (Decrease)
Net Sales
  $ 430.4     $ 456.1     $ (25.7 )     (5.6 )%
     Our net sales decrease of 5.6 percent reflected decreased demand in the medical and defense/security/aerospace sectors, primarily due to decreased end-market demand. This was offset by favorable impacts mainly in the wireless/infrastructure, industrial/commercial and wireline/networking sectors.
     Our net sales by market sector for the indicated periods were as follows:
                 
    Three months ended
    January 2,   January 3,
Market Sector   2010   2009
Wireline/Networking
    47 %     44 %
Wireless Infrastructure
    11 %     10 %
Medical
    18 %     24 %
Industrial/Commercial
    15 %     13 %
Defense/Security/Aerospace
    9 %     9 %
     The percentages of net sales to customers representing 10 percent or more of net sales and net sales to our ten largest customers for the three months ended January 2, 2010 and January 3, 2009 were as follows:
                 
    Three months ended
    January 2,   January 3,
    2010   2009
Juniper
    17 %     18 %
Top 10 customers
    62 %     61 %
     Net sales to our largest customers may vary from time to time depending on the size and timing of customer program commencements, terminations, delays, modifications and transitions. We remain dependent on continued sales to our significant customers, and we generally do not obtain firm, long-term purchase commitments from our customers. Customers’ forecasts can and do change as a result of changes in their end-market demand and other factors, including global economic conditions. Any material change in forecasts or orders from these major accounts, or other customers, could materially affect our results of operations. In addition, as our percentage of net sales to customers in a specific sector becomes larger relative to other sectors, we will become increasingly dependent upon economic and business conditions affecting that sector.
     In the current economic environment, we are seeing increased merger and acquisition activity that may impact our customers. Specifically, two of our customers were acquired in the first fiscal quarter of 2010. We do not believe that there will be a material impact on our expected results in the short run, but in the longer time frame, these transactions create both risk that this business will transition to other contract manufacturers or in house, and opportunities that Plexus could gain additional business with the acquiring entity.

22


Table of Contents

      Gross profit. Gross profit and gross margins for the indicated periods were as follows (dollars in millions):
                                 
    Three months ended    
    January 2,   January 3,   Increase/
    2010   2009   (Decrease)
Gross Profit
  $    44.5     $    46.6     $    (2.1 )        (4.5 )%
Gross Margin
    10.3 %     10.2 %                
     For the three months ended January 2, 2010, gross profit was impacted by the following factors:
    decreased net sales in the medical and defense/security/aerospace sectors
 
    unfavorable changes in customer mix, particularly related to our unnamed defense customer
 
    increased fixed expenses, primarily in the United States reportable segment
 
    offset, in part, by proceeds received from a litigation settlement.
     Even though gross profit decreased, gross margin improved slightly due to a proportionately greater decrease in net sales.
     Gross margins reflect a number of factors that can vary from period to period, including product and service mix, the level of new facility start-up costs, inefficiencies resulting from the transition of new programs, product life cycles, sales volumes, price reductions, overall capacity utilization, labor costs and efficiencies, the management of inventories, component pricing and shortages, the mix of turnkey and consignment business, fluctuations and timing of customer orders, changing demand for our customers’ products and competition within the electronics industry. We are currently in a period of parts shortages for some components, based on lack of capacity at some of our suppliers to meet increased demand from the gradually improving economic outlook, which could affect pricing and/or availability and thus our gross profit and/or net sales. Additionally, turnkey manufacturing involves the risk of inventory management, and a change in component costs can directly impact average selling prices, gross margins and net sales. Although we focus on maintaining gross margins, there can be no assurance that gross margins will not decrease in future periods.
     Design work performed by the Company is not the proprietary property of Plexus and all costs incurred with this work are considered reimbursable by our customers. We do not track research and development costs that are not reimbursed by our customers and we consider these amounts immaterial.
      Selling and administrative expenses. Selling and administrative expenses (S&A) for the indicated periods were as follows (dollars in millions):
                                 
    Three months ended    
    January 2,   January 3,   Increase/
    2010   2009   (Decrease)
S&A
  $    24.3     $    25.3     $    (1.0 )     (4.0 )%
Percent of net sales
    5.7 %     5.5 %                
     For the three months ended January 2, 2010, the dollar decrease in S&A was due primarily to decreased compensation costs related to stock-based compensation, headcount reductions resulting from cost containment actions in fiscal 2009, as well as other continued efforts toward cost containment. This was partially offset by higher variable incentive compensation expense for the current year period. The prior year period also contained an additional week of expenses due to the re-alignment of the fiscal year (see the Executive Summary).
      Restructuring Actions. During the three months ended January 2, 2010, we did not incur any restructuring charges. During the three months ended January 3, 2009, we incurred restructuring charges of $0.6 million related to severance at our Juarez, Mexico facility.

23


Table of Contents

     As of January 2, 2010, we have no remaining restructuring liability. See Note 13 in Notes to the Condensed Consolidated Financial Statements for further information on restructuring costs.
      Income taxes. Income taxes for the indicated periods were as follows (dollars in millions):
                 
    Three months ended
    January 2,   January 3,
    2010   2009
Income tax expense
  $    0.2     $    1.9  
Effective tax rate
    1 %     10 %
     The decrease in the effective tax rate for the three months ended January 2, 2010, compared to the three months ended January 3, 2009, was primarily due to an increase in our projected fiscal 2010 pre-tax income in Malaysia and China, where we currently benefit from tax holidays, when compared to fiscal 2009 pre-tax income.
     Our net deferred income tax assets as of January 2, 2010, reflect a $1.6 million valuation allowance against certain deferred income taxes. We also had a remaining valuation allowance of $1.0 million related to tax deductions associated with stock-based compensation as of January 2, 2010.
     We currently expect the annual effective tax rate for fiscal 2010 to be in the low single digits.
LIQUIDITY AND CAPITAL RESOURCES
      Operating Activities. Cash flows used by operating activities were $10.3 million for the three months ended January 2, 2010, compared to cash flows provided by operating activities of $49.4 million for the three months ended January 3, 2009. During the three months ended January 2, 2010, cash flows used in operating activities were primarily as a result of increased accounts receivable and inventories, partially offset by increased accounts payable, as well as earnings after adjusting for the non-cash effects of depreciation, amortization and stock-based compensation expenses.
     As of January 2, 2010, days sales outstanding in accounts receivable for the current year period were 50 days, which compared unfavorably to the 45 days sales outstanding for fiscal 2009 as a result of increased net sales and the timing of customer payments.
     Our inventory turns decreased to 4.1 turns for the three months ended January 2, 2010, from 4.4 turns for fiscal year ended October 3, 2009. Inventories increased $50.3 million during the three months ended January 2, 2010, primarily as a result of strong revenue growth in the first fiscal quarter from the fourth quarter of fiscal 2009, as well as anticipated continued growth in the second fiscal quarter.
      Investing Activities. Cash flows used in investing activities totaled $12.3 million for the three months ended January 2, 2010, and were primarily for additions to property, plant and equipment in the United States and Asia. These investments were for equipment to support customer demand in those regions and for the construction of a new headquarters building in Neenah, Wisconsin. See Note 9 in Notes to the Condensed Consolidated Financial Statements for further information regarding our first quarter of fiscal 2010 capital expenditures by reportable segment.
     We utilize available cash as the primary means of financing our operating requirements. We currently estimate capital expenditures for fiscal 2010 to be in the range of $65 million to $75 million, of which $12.3 million of expenditures were made during the first quarter of fiscal 2010.
      Financing Activities. Cash flows used in financing activities totaled $2.1 million for the three months ended January 2, 2010, versus $7.4 million for the three months ended January 2, 2009, which primarily represented payments on our outstanding term loan described below, offset by cash generated from exercises of stock options.

24


Table of Contents

     On April 4, 2008, we entered into our Credit Facility with a group of banks which allows us to borrow $150 million in term loans and $100 million in revolving loans. The $150 million in term loans was immediately funded and the $100 million revolving credit facility is currently available. The Credit Facility is unsecured and may be increased by an additional $100 million (the “accordion feature”) if we have not previously terminated all or any portion of the Credit Facility, there is no event of default existing under the credit agreement and both we and the administrative agent consent to the increase. The Credit Facility expires on April 4, 2013. Borrowings under the Credit Facility may be either through term loans, revolving or swing loans or letter of credit obligations. As of January 2, 2010, we had term loan borrowings of $123.8 million outstanding and no revolving borrowings under the Credit Facility.
     The Credit Facility contains certain financial covenants, which include a maximum total leverage ratio, maximum value of fixed rentals and operating lease obligations, a minimum interest coverage ratio and a minimum net worth test, all as defined in the agreement. As of January 2, 2010, we were in compliance with all debt covenants. If we incur an event of default, as defined in the Credit Facility (including any failure to comply with a financial covenant), the group of banks has the right to terminate the Credit Facility and all other obligations, and demand immediate repayment of all outstanding sums (principal and accrued interest). Interest on borrowing varies depending upon our then-current total leverage ratio; as of January 2, 2010, the Company could elect to pay interest at a defined base rate or the LIBOR rate plus 1.25%. Rates would increase upon negative changes in specified Company financial metrics and would decrease upon reduction in the current total leverage ratio to no less than LIBOR plus 1.00%. We are also required to pay an annual commitment fee on the unused credit commitment based on our leverage ratio; the current fee is 0.30 percent. Unless the accordion feature is exercised, this fee applies only to the initial $100 million of availability (excluding the $150 million of term borrowings). Origination fees and expenses associated with the Credit Facility totaled approximately $1.3 million and have been deferred. These origination fees and expenses will be amortized over the five-year term of the Credit Facility. Quarterly principal repayments on the term loan of $3.75 million each began June 30, 2008, and end on April 4, 2013, with a final balloon repayment of $75.0 million.
     The Credit Facility allows for the future payment of cash dividends or the future repurchases of shares provided that no event of default (including any failure to comply with a financial covenant) is existing at the time of, or would be caused by, the dividend payment or the share repurchases.
     In June 2008, the Company entered into three interest rate swap contracts related to the $150 million in term loans under the Credit Facility that have a total notional value of $150 million and mature on April 4, 2013. The total fair value of these interest rate swap contracts was $8.0 million as of January 2, 2010, and the Company has recorded this in “Other” current liabilities and “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets. As of January 2, 2010, the total combined notional amount of the Company’s three interest rate swaps was $123.8 million.
     Our Malaysian operations have entered into forward exchange contracts maturing in fiscal 2010 and fiscal 2011 with a total notional value of $30.6 million. These forward contracts will fix the exchange rates on foreign currency cash used to pay a portion of our local currency expenses. The changes in the fair value of the forward contracts are recorded in “Accumulated other comprehensive income” on the accompanying Condensed Consolidated Balance Sheets until earnings are affected by the variability of cash flows. The total fair value of the forward contracts was $0.7 million at January 2, 2010, and the Company recorded this amount in “Prepaid expenses and other” in the accompanying Condensed Consolidated Balance Sheets.
     As of January 2, 2010, we held $2.0 million of auction rate securities, which were classified as long-term investments and whose underlying assets were in guaranteed student loans backed by a U. S. government agency. Auction rate securities are adjustable rate debt instruments whose interest rates are reset every 7 to 35 days through an auction process, with underlying securities that have original contractual maturities greater than 10 years. Auctions for these investments failed during fiscal 2008, fiscal 2009 and the first quarter of fiscal 2010 and there is no assurance that future auctions on these securities will succeed.

25


Table of Contents

     An auction failure means that the parties wishing to sell their securities could not do so. As a result, our ability to liquidate and fully recover the carrying value of our adjustable rate securities in the near term may be limited or not exist. These developments have resulted in the classification of these securities as long-term investments in our consolidated financial statements. If the issuers of these adjustable rate securities are unable to successfully close future auctions or their credit quality deteriorates, we may in the future be required to record an impairment charge on these investments. We may be required to wait until market stability is restored for these instruments or until the final maturity of the underlying notes to realize our investments’ recorded value.
     Based on current expectations, we believe that our projected cash flows from operations, available cash and short-term investments, the Credit Facility, and our leasing capabilities should be sufficient to meet our working capital and fixed capital requirements for the next twelve months. We currently do not anticipate having to use our Credit Facility to satisfy any of our cash needs. If our future financing needs increase, we may need to arrange additional debt or equity financing. Accordingly, we evaluate and consider from time to time various financing alternatives to supplement our financial resources. However, particularly due to the current instability of the credit and financial markets, we cannot be certain that we will be able to make any such arrangements on acceptable terms.
     We have not paid cash dividends in the past and do not currently anticipate paying them in the future. However, the company evaluates from time to time potential uses of excess cash, which in the future may include share repurchases, a special dividend or recurring dividends.
CONTRACTUAL OBLIGATIONS, COMMITMENTS AND OFF-BALANCE SHEET OBLIGATIONS
     Our disclosures regarding contractual obligations and commercial commitments are located in various parts of our regulatory filings. Information in the following table provides a summary of our contractual obligations and commercial commitments as of January 2, 2010 (dollars in millions):
                                         
    Payments Due by Fiscal Period
                                    2015 and
Contractual Obligations   Total   2010   2011-2012   2013-2014   thereafter
Long-Term Debt Obligations (1)
  $ 123.8     $ 11.3     $ 30.0     $ 82.5     $ -  
Capital Lease Obligations
    30.3       7.6       7.4       7.7       7.6  
Operating Lease Obligations
    40.9       7.5       15.3       11.8       6.3  
Purchase Obligations (2)
    312.3       309.2       3.1       -       -  
Other Long-Term Liabilities on the Balance Sheet (3)
    8.8       1.0       1.6       1.8       4.4  
Other Long-Term Liabilities not on the Balance Sheet (4)
    2.5       0.7       1.8       -       -  
 
                                       
Total Contractual Cash Obligations
  $    518.6     $    337.3     $    59.2     $    103.8     $    18.3  
 
                                       
(1) – As of April 4, 2008, we entered into the Credit Facility and immediately funded a term loan for $150 million. See Note 4 in Notes to Condensed Consolidated Financial Statements for further information.
(2) – As of January 2, 2010, purchase obligations consist of purchases of inventory and equipment in the ordinary course of business.
(3) – As of January 2, 2010, other long-term obligations on the balance sheet included deferred compensation obligations to certain of our former and current executive officers and other key employees, and an asset retirement obligation. We have excluded from the table the impact of approximately $4.0 million, as of January 3, 2010, related to unrecognized income tax benefits. The Company cannot make reliable estimates of the future cash flows by period related to this obligation.
(4) – As of January 2, 2010, other long-term obligations not on the balance sheet consist of a commitment for salary continuation in the event employment of one executive officer of the Company is terminated without cause. We did not have, and were not subject to, any lines of credit, standby letters of credit, guarantees, standby repurchase obligations, other off-balance sheet arrangements or other commercial commitments that are material.

26


Table of Contents

DISCLOSURE ABOUT CRITICAL ACCOUNTING POLICIES
     Our accounting policies are disclosed in our 2009 Report on Form 10-K. During the first quarter of fiscal 2010, there were no material changes to these policies.
NEW ACCOUNTING PRONOUNCEMENTS
     See Note 14 in Notes to Condensed Consolidated Financial Statements for further information regarding new accounting pronouncements.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
     We are exposed to market risk from changes in foreign exchange and interest rates. We selectively use financial instruments to reduce such risks.
Foreign Currency Risk
     We do not use derivative financial instruments for speculative purposes. Our policy is to selectively hedge our foreign currency denominated transactions in a manner that partially offsets the effects of changes in foreign currency exchange rates. We typically use foreign currency contracts to hedge only those currency exposures associated with certain assets and liabilities denominated in non-functional currencies. Corresponding gains and losses on the underlying transaction generally offset the gains and losses on these foreign currency hedges. Our international operations create potential foreign exchange risk. Beginning in July 2009, we entered into forward contracts to hedge a portion of our foreign currency denominated transactions in our Asia reportable segment as described in Note 5 in Notes to Consolidated Financial Statements. Our percentages of transactions denominated in currencies other than the U.S. dollar for the indicated periods were as follows:
                 
    Three months ended
    January 2,   January 3,
    2010   2009
Net Sales
    4 %     3 %
Total Costs
    12 %     10 %
Interest Rate Risk
     We have financial instruments, including cash equivalents and short-term investments, which are sensitive to changes in interest rates. We consider the use of interest-rate swaps based on existing market conditions and have entered into interest rate swaps for $150 million in term loans as described in Note 5 in Notes to Condensed Consolidated Financial Statements. As with any agreement of this type, our interest rate swap agreements are subject to the further risk that the counterparties to these agreements may fail to comply with their obligations thereunder.
     The primary objective of our investment activities is to preserve principal, while maximizing yields without significantly increasing market risk. To achieve this, we maintain our portfolio of cash equivalents and short-term investments in a variety of highly rated securities, money market funds and certificates of deposit and limit the amount of principal exposure to any one issuer.

27


Table of Contents

     Our only material interest rate risk is associated with our Credit Facility under which we borrowed $150 million on April 4, 2008. Through the use of interest rate swaps, as described above, we have fixed the basis on which we pay interest, thus eliminating much of our interest rate risk. A 10 percent change in the weighted average interest rate on our average long-term borrowings would have had only a nominal impact on net interest expense for the three months ended January 2, 2010.
Auction Rate Securities
     As of January 2, 2010, we held $2.0 million of auction rate securities, which were classified as long-term other assets. On February 21, 2008, we were unable to liquidate these investments, whose underlying assets were in guaranteed student loans backed by a U.S. government agency. Additional auctions for these investments failed during fiscal 2008, fiscal 2009 and in the first quarter of fiscal 2010. We have the ability and intent to hold these securities until a successful auction occurs and these securities are liquidated at par value. At this time, we believe that the securities will eventually be recovered. However, we may be required to hold these securities until market stability is restored for these instruments or final maturity of the underlying notes to realize our investments’ recorded value. Accordingly, we have classified these securities as long-term other assets.
ITEM 4. CONTROLS AND PROCEDURES
      Disclosure Controls and Procedures: The Company maintains disclosure controls and procedures designed to ensure that the information the Company must disclose in its filings with the Securities and Exchange Commission (“SEC”) is recorded, processed, summarized and reported on a timely basis. The Company’s principal executive officer and principal financial officer have reviewed and evaluated, with the participation of the Company’s management, the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based on such evaluation, the chief executive officer and chief financial officer have concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective (a) in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act, and (b) in assuring that information is accumulated and communicated to the Company’s management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
      Changes in Internal Control Over Financial Reporting: During the first quarter of fiscal 2010, there have been no changes to the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
      Limitations on the Effectiveness of Controls: Our management, including our chief executive officer and chief financial officer, does not expect that our disclosure controls and internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
     Notwithstanding the foregoing limitations on the effectiveness of controls, we have nonetheless reached the conclusion that the Company’s disclosure controls and procedures are effective at the reasonable assurance level.

28


Table of Contents

PART II. OTHER INFORMATION
ITEM 1. Legal Proceedings
     We were notified in April 2009 by U.S. Customs and Border Protection (“CBP”) of its intention to conduct a customary Focused Assessment of our import activities during fiscal 2008 and of our processes and procedures to comply with U.S. Customs laws and regulations. As a result of discussions with CBP, by June 2010, Plexus has committed to CBP that it will report any errors, and tender any associated duties and fees, relating to import trade activity. Plexus has also agreed that it will implement improved processes and procedures in areas where errors are found and review these corrective measures with CBP. At this time, we do not believe that any deficiencies in processes or controls, or unanticipated costs, unpaid duties or penalties associated with this matter, will have a material adverse effect on Plexus or our results of operations.
     The Company is party to certain other lawsuits in the ordinary course of business. Management does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.
ITEM 1A. Risk Factors
     In addition to the risks and uncertainties discussed herein, see the risk factors set forth in Part I, Item 1A of the Company’s annual report on Form 10-K for the year ended October 3, 2009.
ITEM 6. EXHIBITS
     
10.1
  Amended and Restated Plexus Corp. 2008 Long-Term Incentive Plan. *
 
   
10.2
  Form of Plexus Corp. Non-Qualified Stock Option Agreement. *
 
   
10.3
  Form of Plexus Corp. Unrestricted Stock Award. **
 
   
10.4
  Plexus Corp. Non-Employee Directors Deferred Compensation Plan. ***
 
   
31.1
  Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes Oxley Act of 2002.
 
   
31.2
  Certification of Chief Financial Officer pursuant to section 302(a) of the Sarbanes Oxley Act of 2002.
 
   
32.1
  Certification of the CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
   
32.2
  Certification of the CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
*   Reflects non-material changes that were finalized in January 2010.
 
**   Form of award consistent with the 2008 Long-Term Incentive Plan.
 
***   Memorialization of current policy filed for reference. Not deemed to be a material change from current procedures.

29


Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
 
  Plexus Corp.
 
  Registrant
 
   
 
   
2/4/10
  /s/ Dean A. Foate
Date
  Dean A. Foate
 
  President and Chief Executive Officer
 
   
 
   
 
   
2/4/10
  /s/ Ginger M. Jones
Date
  Ginger M. Jones
 
  Vice President and Chief Financial Officer

30

Exhibit 10.1
Amended and restated as of August 28, 2008
(as further amended effective January 5, 2010)
PLEXUS CORP.
2008 LONG-TERM INCENTIVE PLAN
1. Introduction .
  (a)   Purposes . The purposes of the 2008 Long-Term Incentive Plan are to provide a means to attract and retain talented personnel and to provide to participating directors, officers and other key employees long-term incentives for high levels of performance and for successful efforts to improve the financial performance of the corporation. These purposes may be achieved through the grant of options to purchase Common Stock of Plexus Corp., the grant of Stock Appreciation Rights, the grant of Restricted Stock, the grant of Performance Stock Awards, the grant of Unrestricted Stock Awards and the grant of Cash Bonus Awards, as described below.
 
  (b)   Effect on Prior Plans . If the 2008 Plan is approved by shareholders, the Plexus Corp. 2005 Equity Incentive Plan (the “2005 Plan”) will only be used to make grants to employees covered by the approved sub-plan for United Kingdom employees which has been established under the 2005 Plan. If and when a sub-plan for United Kingdom employees under the 2008 Plan is approved, no further awards will be granted under the Plexus Corp. 2005 Plan. Awards granted previously under the 2005 Plan will remain in effect until they have been exercised or have expired. The awards shall be administered in accordance with their terms and the 2005 Plan.
2. Definitions .
  (a)   “1934 Act” means the Securities Exchange Act of 1934, as it may be amended from time to time.
 
  (b)   “Award” means an Incentive Stock Option, Non-Qualified Stock Option, Stock Appreciation Right, Restricted Stock grant, Performance Stock Award, Unrestricted Stock Award or Cash Bonus Award, as appropriate.
 
  (c)   “Award Agreement” means the agreement between the Corporation and the Grantee specifying the terms and conditions as described thereunder.
 
  (d)   “Board” means the Board of Directors of Plexus Corp.
 
  (e)   “Cash Bonus Award” means a cash bonus award under Article 16 of the Plan.
 
  (f)   “Cause” means a violation of the Corporation’s Code of Conduct and Business Ethics, or substantial and continued failure of the employee to perform, which results in, or was intended to result in (i) demonstrable injury to the Corporation, monetary or otherwise or (ii) gain to, or enrichment of, the Grantee at the Corporation’s expense.
 
  (g)   “Change in Control” means an event which shall be deemed to have occurred in the event that any person, entity or group shall become the beneficial owner of such number of shares of Common Stock, and/or any other class of stock of the Corporation then outstanding that is entitled to vote in the election of directors (or is convertible into shares so entitled to vote) as together possess more than 50% of the voting power of all of the then outstanding shares of all such classes of stock of the Corporation so entitled to vote. For purposes of the preceding sentence, “person, entity or group” shall not include (i) any employee benefit plan of the Corporation, or (ii) any person, entity or group which, as of the Effective Date of this Plan, is the beneficial owner of such number of shares of Common Stock and/or such other class of stock of the Corporation as together possess 5% of such voting power; and for these purposes “group” shall mean persons who act in concert as described in Section 14(d)(2) of the 1934 Act.

-1-


 

  (h)   “Code” means the Internal Revenue Code of 1986, as it may be amended from time to time.
 
  (i)   “Committee” means the committee described in Article 4 or the person or persons to whom the committee has delegated its power and responsibilities under Article 4.
 
  (j)   “Common Stock” or “Stock” means the common stock of the Corporation having a par value of $.01 per share.
 
  (k)   “Corporation” means Plexus Corp., a Wisconsin corporation.
 
  (l)   “Fair Market Value” means for purposes of the Plan an amount deemed to be equal to the mean between the highest and lowest sale prices of Common Stock traded on such date, or an average of trading days, as determined by the Committee, for sales made and reported through the National Market System of the National Association of Securities Dealers or such national stock exchange on which such Stock may then be listed and which constitutes the principal market for such Stock, or, if no sales of Stock shall have been reported with respect to that date, on the next preceding date with respect to which sales were reported. Notwithstanding the foregoing, the Committee may base the determination of Fair Market Value on an average of trading days only if the requirements for the use of such methodology prescribed by applicable guidance under Section 409A of the Code are satisfied.
 
  (m)   “Grant Date” means the date on which an Award is deemed granted, which shall be the date on which the Committee authorizes the Award or such later date as the Committee shall determine in its sole discretion.
 
  (n)   “Grantee” means an individual who has been granted an Award.
 
  (o)   “Incentive Stock Option” means an option that is intended to meet the requirements of Section 422 of the Code and regulations thereunder.
 
  (p)   “Non-Qualified Stock Option” means an option other than an Incentive Stock Option.
 
  (q)   “Option” means an Incentive Stock Option or Non-Qualified Stock Option, as appropriate.
 
  (r)   “Performance Goal” means a performance goal established by the Committee prior to the grant of any Award of Restricted Stock or Performance Stock that is based on the attainment of goals relating to one or more of the following business criteria measured on an absolute basis or in terms of growth or reduction: income (pre-tax or after-tax and with adjustments as stipulated), earnings per share, return on equity, return on capital employed, return on assets, return on tangible book value, operating income, earnings before depreciation, interest, taxes and amortization (EBIDTA), expense ratio, increase in stock price, return on invested capital (ROIC), total shareholder return, shareholder value added (or a derivative thereof) and operating cash flow. Such performance goals may be based solely by reference to the Corporation’s performance or the performance of an affiliate, division, business segment or business unit of the Corporation or any of its subsidiaries, or based upon the relative performance of other companies or upon comparisons of any of the indicators of performance relative to other companies. The Committee may also exclude charges related to an event or occurrence which the Committee determines should appropriately be excluded, including (i) restructurings, discontinued operations, impairment of goodwill or long-lived assets, extraordinary items, and other unusual or non-recurring charges, (ii) an event either not directly related to the operations of the Corporation or not within the reasonable control of the Corporation’s management, or (iii) the cumulative effects of tax or accounting changes in accordance with generally accepted accounting principles.

-2-


 

  (s)   “Performance Stock Award” means an Award under Article 16 of the Plan that is conditioned upon the satisfaction of pre-established Performance Goals.
 
  (t)   “Plan” means the Plexus Corp. 2008 Long-Term Incentive Plan as set forth herein, as it may be amended from time to time.
 
  (u)   “Rule 16b-3” means Rule 16b-3 promulgated under the 1934 Act, and any future regulation amending or superseding such regulation.
 
  (v)   “Restricted Stock” means shares or units of Common Stock which are subject to restrictions established by the Committee. Restricted Stock Awards may consist of shares issued subject to forfeiture if specified conditions are not satisfied (“Restricted Stock Shares”) or agreements to issue shares of Common Stock in the future if specified conditions are satisfied (“Restricted Stock Units”).
 
  (w)   “Stock Appreciation Right” or “SAR” means the right to receive cash or shares of Common Stock in an amount equal to the excess of the Fair Market Value of one share of Common Stock on the date the SAR is exercised over (1) the Fair Market Value of one share of Common Stock on the Grant Date (the “exercise price”) or (2) if the SAR is related to an Option, the purchase price of a share of Common Stock specified in the related Option. An SAR settled in cash may be referred to as a “Cash Settled Stock Appreciation Right” and an SAR settled in stock may be referred to as a “Stock Settled Stock Appreciation Right.”
 
  (x)   “Deferred Stock Unit” means an agreement to issue an unrestricted share of Common Stock at a time determined in accordance with the Grantee’s election and the terms of the Director Deferred Compensation Plan.
 
  (y)   “Director Deferred Compensation Plan” means the Plexus Corp. Non-Employee Directors Deferred Compensation Plan.
 
  (z)   “Unrestricted Stock Award” means an Award described in Article 16A.
3. Shares Subject to Award .
     Subject to adjustment as provided in Article 19 hereunder, the number of shares of Common Stock of the Corporation that may be issued under the Plan shall not exceed five million five hundred thousand (5,500,000) shares (the “Share Limit”), all of which may be issued in the form of Incentive Stock Options. No Plan Participant may receive Awards for more than 1,000,000 Shares in any calendar year. Shares issued under the Plan may come from authorized but unissued shares, from treasury shares held by the Corporation, from shares purchased by the Corporation or an independent agent in the open market for such purpose, or from any combination of the foregoing. The Share Limit shall be subject to the following rules and adjustments:
  (a)   If an SAR is exercised pursuant to Article VI, only the number of shares of Common Stock issued upon exercise shall be counted against the Share Limit (not the number of shares subject to the SAR).
 
  (b)   If any Award granted under this Plan is canceled, terminates, expires, or lapses for any reason, any shares subject to such Award again shall be available for the grant of an Award under the Plan. Any Awards or portions thereof that are settled in cash and not in shares of Common Stock shall not be counted against the foregoing Share Limit.

-3-


 

  (c)   Following the approval of the 2008 Plan by shareholders, the 2005 Plan may be used to make grants to employees covered by the approved sub-plan for United Kingdom employees under the 2005 Plan. Any shares of Common Stock subject to options which are granted to United Kingdom employees after the 2008 Plan has been approved by shareholders shall be counted against the 2008 Plan Share Limit as one share for every one share subject thereto.
4. Administration of the Plan .
     For purposes of the power to grant Awards to directors, the Committee shall consist of the entire Board. For other Plan purposes, the Plan shall be administered by the Compensation and Leadership Development Committee of the Board, or any other committee the Board may subsequently appoint to administer the Plan, as herein described. The Committee shall have full and final authority, in its discretion, but subject to the express provisions of the Plan to:
  (a)   grant Awards, to determine the terms of each Award, the individuals to whom, the number of shares subject to, and the time or times at which, Awards shall be granted;
 
  (b)   interpret the Plan;
 
  (c)   prescribe, amend and rescind rules and regulations relating to the Plan;
 
  (d)   determine the terms and provisions of the respective agreements (which need not be identical) by which Awards shall be evidenced;
 
  (e)   make all other determinations deemed necessary or advisable for the administration of the Plan;
 
  (f)   require withholding from or payment by a Grantee of any federal, state or local taxes;
 
  (g)   impose, on any Grantee, such additional conditions, restrictions and limitations upon exercise and retention of Awards as the Committee shall deem appropriate;
 
  (h)   treat any Grantee who retires as a continuing employee for purposes of the Plan; and
 
  (i)   modify, extend or renew any Award previously granted; provided, however, that this provision shall not provide authority to reprice Awards to a lower exercise price.
     Any action of the Committee with respect to the administration of the Plan shall be taken pursuant to a majority vote or by the unanimous written consent of its members. The Committee may delegate all or any part of its responsibilities and powers to any executive officer or officers of the Corporation selected by it. Any such delegation may be revoked by the Board or by the Committee at any time.
5. Option Participation .
     Options may be granted to directors, officers and key employees of the Corporation and any of its subsidiaries. In selecting the individuals to whom Options shall be granted, as well as in determining the number of Options granted, the Committee shall take into consideration such factors as it deems relevant pursuant to accomplishing the purposes of the Plan. A Grantee may, if otherwise eligible, be granted an additional Option or Options if the Committee shall so determine.
6. Granting of Options .
     The officers of the Corporation are authorized and directed, upon receipt of notice from the Committee of the granting of an Option, to deliver on behalf of the Corporation, by mail or otherwise, to the Grantee an Option upon the terms and conditions specified under the Plan and in the form of the Award Agreement. The Award Agreement shall be dated as of the date of approval of the granting of an Option by the Committee. If the Grantee fails to accept the Award within 30 days after the date of its delivery to Grantee, the Option grant may be deemed withdrawn.

-4-


 

     Where an Option has been granted under the provisions of the HM Revenue & Customs Approved Rules for UK Employees (the “Sub-Plan”) and the number of shares of Common Stock subject to that Option is limited by virtue of Rule 17 of the Sub-Plan, there shall be deemed to have been granted a separate Option (for the avoidance of doubt, not granted under the provisions of the Sub-Plan) on the same date and time and under the same terms for the number of shares of Common Stock in excess of the limit set out in Rule 17 of the Sub-Plan.
7. Option Exercise Price .
     The purchase price of the Common Stock covered by each Option shall be not less than the Fair Market Value of such Stock on the Grant Date. Such price shall be subject to adjustment as provided in Article 19 hereof.
8. Option Designation .
     At the time of the grant of each Option, the Committee shall designate the Option as (a) an Incentive Stock Option or (b) a Non-Qualified Stock Option, as described in Sections (a) and (b) below, respectively.
  (a)   Incentive Stock Options : Any Option designated as an Incentive Stock Option shall comply with the requirements of Section 422 of the Code, including the requirement that incentive stock options may only be granted to individuals who are employed by the Corporation, a parent or a subsidiary corporation of the Corporation. If an Option is so designated, the Fair Market Value (determined as of the Grant Date) of the shares of Stock with respect to which that and any other Incentive Stock Option first becomes exercisable during any calendar year under this Plan or any other stock option plan of the Corporation or its affiliates shall not exceed $100,000; provided, however, that the time or times of exercise of an Incentive Stock Option may be accelerated pursuant to Article 12, 13 or 19 hereof, terms of the Plan and, in the event of such acceleration, such Incentive Stock Option shall be treated as a Non-Qualified Option to the extent that the aggregate Fair Market Value (determined as of the Grant Date) of the shares of stock with respect to which such Option first becomes exercisable in the calendar year (including Options under this Plan and any other Plan of the corporation or its affiliates) exceeds $100,000, the extent of such excess to be determined by the Committee taking into account the order in which the Options were granted, or such other factors as may be consistent with the requirements of Section 422 of the Code and rules promulgated thereunder. Furthermore, no Incentive Stock Option shall be granted to any individual who, immediately before the Option is granted, directly or indirectly owns (within the meaning of Section 425(d) of the Code, as amended) shares representing more than 10% of the total combined voting power of all classes of stock of the Corporation or its subsidiaries, unless, at the time the option is granted, and in accordance with the provisions of Section 422, the option exercise price is 110% of the Fair Market Value of shares of Stock subject to the Option and the Option must be exercised within 5 years of the Grant Date.
 
  (b)   Non-Qualified Stock Options : All Options not subject to or in conformance with the additional restrictions required to satisfy Section 422 shall be designated Non-Qualified Stock Options.
9. Stock Appreciation Rights .
     The Committee may, in its discretion, grant SARs to directors, officers and key employees of the Corporation and any of its subsidiaries. If any unexercised SAR for any reason terminates or expires in whole or in part prior to termination of the Plan, such unexercised SARs shall become available for granting under the Plan. The Committee may grant SARs at any time and from time to time to any Grantee, designate such SARs as related to Options then being granted or granted within six months prior to the Grant Date of the SAR, and set such terms and conditions upon the exercise of the SARs as it may determine in its discretion, provided that the written agreement evidencing such SARs shall comply with and be subject to the following terms and conditions:

-5-


 

  (a)   No SAR granted hereunder shall be exercisable until the expiration of six months from the Grant Date of the SAR unless the Grantee terminates employment by reason of death or disability prior to the expiration of such six-month period.
 
  (b)   A Grantee’s right to exercise an SAR shall terminate when the Grantee is no longer an employee of the Corporation or any of its subsidiaries unless such right is extended as provided under Article 13 hereunder.
 
  (c)   In the event adjustments are made to the number of shares, exercise price, or time or times of exercise of outstanding Options upon the occurrence of an event described in Article 19 hereunder, appropriate adjustments shall be made in the number of SARs available for future grant, the number of SARs under existing grants, the exercise price of the existing SARs, and the time or times of exercise of such SARs.
 
  (d)   Unless the written agreement expressly provides otherwise, if and to the extent an SAR is granted in relation to an Option, exercise of the SAR or Option shall result in the extinguishment of the related right to the extent such SAR or Option for shares is exercised.
 
  (e)   Unless the written agreement expressly provides otherwise, any SARs granted shall be exercisable in accordance with Article 12.
 
  (f)   Upon the exercise of SARs, the Grantee shall be entitled to receive an amount determined by multiplying (1) the difference obtained by subtracting the Fair Market Value of the share of Common Stock as of the Grant Date of the SAR or, in the case of a SAR which is related to an Option, the purchase price per share of Common Stock under such Option, from the Fair Market Value of a share of Common Stock on the date of exercise, by (2) the number of SARs exercised. At the discretion of the Committee, the payment upon the exercise of the SARs may be in cash, in shares of Common Stock of equivalent value, or in some combination thereof. The number of available shares under Award shall not be affected by any cash payments.
10. Non-transferability of Options and SARs .
     Any Option or SAR granted hereunder shall, by its terms, be non-transferable by a Grantee other than by will or the laws of descent and shall be exercisable during the Grantee’s lifetime solely by the Grantee or the Grantee’s duly appointed guardian or personal representative. Notwithstanding the foregoing, the Committee may permit a Grantee to transfer a Non-Qualified Stock Option or SAR to a family member or a trust or partnership for the benefit of a family member, in accordance with rules established by the Committee.
11. Substituted Options or SARs .
     In the event the Committee cancels any Option or SAR granted under this Plan, and a new Option or SAR is substituted therefore, the Grant Date of the canceled Option or SAR (except to the extent inconsistent with the restrictions described in Article 8, if applicable) shall be the date used to determine the earliest date for exercising the new substituted Option under Article 12 hereunder so that the Grantee may exercise the substituted Option or SAR at the same time as if the Grantee had held the substituted Option or SAR since the Grant Date of the canceled Option. Except in connection with a corporate transaction involving the Corporation (including, without limitation, any stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, or exchange of shares), the terms of outstanding Awards may not be amended to reduce the exercise price of outstanding Options or SARs or cancel outstanding Options or SARS in exchange for cash, other awards or Options or SARs with an exercise price that is less than the exercise price of the original Options or SARs without stockholder approval. Nothing in this Section 11 shall provide authority to substitute Awards in a manner which will have the effect of repricing Awards to a lower exercise price.

-6-


 

12. Vesting of Options and SARs .
     The Committee shall have the power to set the time or times within which each Option and SAR shall be exercisable, and to accelerate the time or times of exercise. If an SAR is related to an Option, the Grant Date of such SAR for purposes of this Article 12 shall be the Grant Date of the related Option. No Option or SAR may be exercised if in the opinion of counsel for the Corporation the issuance or sale of Stock or payment of cash by the corporation, as appropriate, pursuant to such exercise shall be unlawful for any reason, nor after the expiration of 10 years from the Grant Date. In no event shall the Corporation be required to issue fractional shares upon the exercise of an Option.
13. Exercise Period for Options and SARs .
     Unless otherwise provided herein or in a specific Option or SAR Agreement which may provide longer or shorter periods during which the Award may be exercised, no Option or SAR shall be exercisable after the earliest of:
  (a)   in the case of an Incentive Stock Option:
  (i)   10 years from the date the option is granted, or five years from the date the option is granted to an individual owning (after the application of the family and other attribution rules of Section 424(d) of the Code) at the time such option was granted, more than 10% of the total combined voting power of all classes of stock of the Corporation,
 
  (ii)   three months after the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is for any reason other than death, disability (within the meaning of Code Section 22(e)(3)), retirement or Cause,
 
  (iii)   three years after the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is by reason of the Grantee’s death, disability (within the meaning of Code Section 22(e)(3)) or retirement in accordance with normal Corporation retirement practices, as determined by the Committee in its sole discretion (provided that such Option must be exercised within the time period prescribed by Section 422 of the Code to be treated as an Incentive Stock Option); or
 
  (iv)   the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is for Cause, as determined by the Corporation or the Committee in its sole discretion;
  (b)   in the case of a Nonqualified Stock Option:
  (i)   ten (10) years from the date of grant,
 
  (ii)   ninety days after the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is for any reason other than death, permanent disability, retirement or Cause,
 
  (iii)   three years after the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is by reason of the Grantee’s death, permanent disability or retirement in accordance with normal Corporation retirement practices, as determined by the Committee in its sole discretion; or
 
  (iv)   the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is for Cause, as determined by the Corporation or the Committee in its sole discretion;

-7-


 

  (c)   in the case of an SAR:
  (i)   seven (7) years from the date of grant,
 
  (ii)   ninety days after the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is for any reason other than death, permanent disability, retirement or Cause,
 
  (iii)   one year after the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is by reason of death or permanent disability,
 
  (iv)   three years after the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is by reason of the Grantee’s retirement in accordance with normal Corporation retirement practices, as determined by the Committee in its sole discretion; or
 
  (v)   the date the Grantee ceases to perform services for the Corporation or its subsidiaries, if such cessation is for Cause, as determined by the Corporation or the Committee in its sole discretion;
provided, that, unless otherwise provided in a specific grant agreement or determined by the Committee, an Option or SAR shall only be exercisable for the periods above following the date an optionee ceases to perform services to the extent the option was exercisable on the date of such cessation. Notwithstanding the foregoing, no Option or SAR shall be exercisable after the date of expiration of its term.
14. Method of Exercise .
     To the extent that the right to purchase shares pursuant to an Option or to exercise an SAR has accrued hereunder, such Option or SAR may be exercised as follows:
  (a)   Options : Options may be exercised in whole or in part from time to time as specified in the Option agreement. The exercise notice shall state the number of shares being purchased and be accompanied by the payment in full of the exercise price for such shares. Such payment shall be made in cash, outstanding shares of the Common Stock which the Grantee, the Grantee’s spouse or both have beneficially owned for at least six months prior to the time of exercise, or in combinations thereof. If  shares of Common Stock are used in part or full payment for the shares to be acquired upon exercise of the Option, such shares shall be valued for the purpose of such exchange as of the date of exercise of the Option at the Fair Market Value of the shares.
 
  (b)   SARs : SARs may be exercised in whole or in part from time to time as specified in the SAR agreement.
15. Restricted Stock Awards .
     The Committee may, in its discretion, grant Restricted Stock to directors, officers and key employees of the Corporation and any of its subsidiaries. Restricted Stock Awards may consist of shares issued subject to forfeiture if specified conditions are not satisfied (“Restricted Stock Shares”) or agreements to issue shares of Common Stock in the future if specified conditions are satisfied (“Restricted Stock Units”). The Committee may condition the grant of Restricted Stock upon the attainment of Performance Goals so that the grant qualifies as “performance-based compensation” within the meaning of Section 162(m) of the Code. The Committee may also condition the grant of Restricted Stock upon such other conditions, restrictions and contingencies as the Committee may determine. The provisions of Restricted Stock Awards need not be the same with respect to each recipient. Restricted Stock Awards shall be subject to the following terms and conditions:
  (a)   Each Restricted Stock Award shall be confirmed by, and be subject to the terms of, an Award Agreement identifying the restrictions applicable to the Award.

-8-


 

  (b)   Until the applicable restrictions lapse or the conditions are satisfied, the Grantee shall not be permitted to sell, assign, transfer, pledge or otherwise encumber the Restricted Stock Award.
 
  (c)   Except to the extent otherwise provided in the applicable Award Agreement and (d) below, the portion of the Restricted Stock Award still subject to restriction shall be forfeited by the Grantee upon termination of the Grantee’s service for any reason.
 
  (d)   In the event of hardship or other special circumstances of a Grantee whose service is terminated (other than for Cause), the Committee may waive in whole or in part any or all remaining restrictions with respect to such Grantee’s Restricted Stock Award.
 
  (e)   If and when the applicable restrictions lapse, unrestricted shares of Common Stock shall be issued to the Grantee.
 
  (f)   A Grantee receiving an Award of Restricted Stock Shares shall have all of the rights of a shareholder of the Corporation, including the right to vote the shares and the right to receive any cash dividends. Unless otherwise determined by the Committee, cash dividends shall be paid in cash and dividends payable in stock shall be paid in the form of additional Restricted Stock Shares.
 
  (g)   A Grantee receiving an Award of Restricted Stock Units shall not be deemed the holder of any shares covered by the Award, or have any rights as a shareholder with respect thereto, until such shares are issued to him/her.
16. Performance Stock Awards.
     The Committee may grant Performance Stock Awards either alone or in addition to other Awards granted under the Plan. The Committee anticipates that the Performance Stock Awards will be subject to both a performance condition and a condition related to the Grantee’s continued employment. The Committee shall determine the eligible employees to whom and the time or times at which Performance Stock Awards will be made, the number of shares subject to the Award, the time or times within which such Awards will be subject to forfeiture and any other terms and conditions of the Awards. Performance Stock Awards shall be subject to the following terms and conditions:
  (a)   The Performance Stock Awards will be conditioned upon the attainment of one or more preestablished, objective corporate Performance Goals so that the Award qualifies as “performance-based compensation” within the meaning of Section 162(m) of the Code. Performance Goals shall be based on one or more business criteria that apply to the individual, a business unit, or the Corporation as a whole. It is intended that any Performance Goal will be in a form that relates the Performance Stock Award to an increase in the value of the Corporation to its shareholders.
 
  (b)   Performance Goals shall be established in writing by the Committee not later than 90 days after the commencement of the period of service to which the Performance Goal relates. The preestablished Performance Goal must state, in terms of an objective formula or standard, the method for computing the number of shares earned or subject to further vesting conditions if the goal is attained.
 
  (c)   Following the close of the performance period, the Committee shall determine whether the Performance Goal was achieved, in whole or in part, and determine the number of shares earned or subject to further vesting conditions.
 
  (d)   The Performance Stock Awards may be conditioned upon such other conditions, restrictions and contingencies as the Committee may determine, including the Grantee’s continued employment. The provisions of Performance Stock Awards need not be the same with respect to each recipient.

-9-


 

  (e)   Until all conditions for a Performance Stock Award have been satisfied, the Grantee shall not be permitted to sell, assign, transfer, pledge or otherwise encumber the Award.
 
  (f)   Except to the extent otherwise provided by the Committee and (g) below, the portion of the Award still subject to restriction shall be forfeited by the Grantee upon termination of a Grantee’s service for any reason.
 
  (g)   In the event of hardship or other special circumstances of a Grantee whose employment is terminated (other than for Cause), the Committee may waive in whole or in part any or all remaining restrictions with respect to such Grantee’s Performance Stock Award.
 
  (h)   If and when the applicable restrictions lapse, unrestricted shares of Common Stock for such shares shall be issued to the Grantee.
     A Grantee receiving a Performance Stock Award shall not be deemed the holder of any shares covered by the Award, or have any rights as a shareholder with respect thereto, until such shares are issued to him/her following the lapse of the applicable restrictions.
16A. Unrestricted Stock Awards .
  (a)   The Committee may grant Unrestricted Stock Awards, either alone or in addition to other Awards granted under the Plan. Except as otherwise provided in Section 16A(b), an Unrestricted Stock Award shall consist of unrestricted shares of Common Stock.
 
  (b)   To the extent permitted by the Committee in its discretion and in accordance with Section 409A of the Code, a Grantee who is a non-employee director of the Corporation may elect to defer receipt of the Stock covered by an Unrestricted Stock Award pursuant to a valid election under the Director Deferred Compensation Plan, in which event such Grantee’s Award shall consist of Deferred Stock Units. A Grantee receiving an Award of Deferred Stock Units shall not be deemed the holder of any Shares covered by the Award, or have any rights as a shareholder with respect thereto, until such Shares are issued to him/her in payment of such Deferred Stock Units. The timing of the issuance of such Shares, and the timing of payment of any dividends payable with respect to the Shares underlying the Deferred Stock Units, shall be determined in accordance with the terms of the Director Deferred Compensation Plan and the Grantee’s election thereunder.
 
  (c)   Unrestricted Stock Awards shall be evidenced in such manner as the Committee shall determine.
17. Cash Bonus Awards .
     The Committee may establish Cash Bonus Awards either alone or in addition to other Awards granted under the Plan. The Committee shall determine the employees to whom and the time or times at which Cash Bonus Awards shall be granted, and the conditions upon which such Awards will be paid. The maximum Cash Bonus Award payable to an employee in any fiscal year shall not exceed $1,500,000. Cash Bonus Awards shall be subject to the following terms and conditions:
  (a)   A Cash Bonus Award under the Plan shall be paid solely on account of the attainment of one or more preestablished, objective Performance Goals. Performance Goals shall be based on one or more business criteria that apply to the individual, a business unit, or the Corporation as a whole. It is intended that any Performance Goal will be in a form that relates the bonus to an increase in the value of the Corporation to its shareholders.
 
  (b)   Performance Goals shall be established in writing by the Committee not later than 90 days after the commencement of the period of service to which the Performance Goal relates The pre-established Performance Goal must state, in terms of an objective formula or standard, the method for computing the amount of compensation payable to any employee if the goal is attained.

-10-


 

  (c)   Following the close of the performance period, the Committee shall determine whether the Performance Goal was achieved, in whole or in part, and determine the amount payable to each employee.
     This Plan does not limit the authority of the Corporation, the Board or the Committee, or any Subsidiary to award bonuses or authorize any other compensation to any person.
18. Withholding .
     The Corporation shall have the power and the right to deduct or withhold, or require a Grantee to remit to the Corporation, an amount sufficient to satisfy Federal, state, and local taxes (including the Grantee’s FICA obligation) required by law to be withheld with respect to any taxable event arising or as a result of this Plan. With respect to withholding required upon the exercise of Options or SARs, upon the lapse of restrictions on Restricted Stock or the payment of Performance Stock Awards, Grantees may elect, subject to the approval of the Committee, to satisfy the withholding requirement, in whole or in part, by having the Corporation withhold shares having a Fair Market Value on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.
19. Effect of Change in Stock Subject to Plan .
     In the event of a reorganization, recapitalization, stock split, stock dividend, merger, consolidation, rights offering or like transaction, the Committee will make such adjustment in the number of and class of shares which may be delivered under the Plan, and in the number and class of and/or price of shares subject to outstanding Options, SARs, Restricted Stock, Performance Stock and Unrestricted Stock Awards granted under the Plan as it may deem to be equitable. While the Committee must make such an adjustment, the determination by the Committee as to what is equitable shall be at its discretion. Notwithstanding, in the event of the merger or consolidation of the Corporation with or into another corporation or corporations in which the Corporation is not the surviving corporation, the adoption of any plan for the dissolution of the Corporation, or the sale or exchange of all or substantially all the assets of the Corporation for cash or for shares of stock or other securities of another corporation, the Committee may, subject to the approval of the Board of Directors of the Corporation, or the board of directors of any corporation assuming the obligations of the Corporation hereunder, take action regarding each outstanding and unexercised Option and SAR pursuant to either clause (a) or (b) below:
  (a)   Appropriate provision may be made for the protection of such Option and SAR by the substitution on an equitable basis of appropriate shares of the surviving or related corporation, provided that the excess of the aggregate Fair Market Value of the  shares subject to such Award immediately before such substitution over the exercise price thereof is not more than the excess of the aggregate fair market value of the substituted shares made subject to Award immediately after such substitution over the exercise price thereof; or
 
  (b)   The Committee may cancel such Award. In the event any Option or SAR is canceled, the Corporation, or the corporation assuming the obligations of the Corporation hereunder, shall pay the Grantee an amount of cash (less normal withholding taxes) equal to the excess of the Fair Market Value per share of the Stock immediately preceding the cancellation over the exercise price, multiplied by the number of shares subject to such Option or SAR. In the event any other Award is canceled, the Corporation, or the corporation assuming the obligations of the Corporation hereunder, shall pay the Grantee an amount of cash or stock, as determined by the Committee, based upon the value, as determined by the Committee, of the property (including cash) received by the holder of a share of Common Stock as a result of such event. No payment shall be made to a Grantee for any Option or SAR if the exercise price for such Option or SAR exceeds the value, as determined by the Committee, of the property (including cash) received by the holder of a share of Common Stock as a result of such event.
     Notwithstanding anything to the contrary, in the event a Change in Control should occur, all Options, SARs, Restricted Stock Shares and Restricted Stock Units then outstanding shall become immediately vested or exercisable upon the date of the Change in Control. Further, the Committee shall have the right to cancel such Options or SARs and pay the Grantee an amount determined under (b) above.

-11-


 

20. Liquidation .
     Upon the complete liquidation of the Corporation, any unexercised Options and SARs theretofore granted under this Plan shall be deemed canceled.
21. No Employment or Retention Agreement Intended .
     Neither the establishment of, nor the awarding of Awards under this Plan shall be construed to create a contract of employment or service between any Grantee and the Corporation or its subsidiaries; nor does it give any Grantee the right to continued service in any capacity with the Corporation or its subsidiaries or limit in any way the right of the Corporation or its subsidiaries to discharge any Grantee at any time and without notice, with or without Cause, or to any benefits not specifically provided by this Plan, or in any manner modify the Corporation’s right to establish, modify, amend or terminate any profit sharing or retirement plans.
22. Shareholder Rights .
     Grantee shall not, by reason of any Options granted hereunder, have any right of a shareholder of the Corporation with respect to the shares covered by the Options until shares of Stock have been issued to Grantee.
23. Controlling Law .
     The law of the State of Wisconsin, except its law with respect to choice of law, shall be controlling in all matters relating to the Plan.
24. Indemnification .
     In addition to such other rights of indemnification as they may have, the members of the Committee and other Corporation employees administering the Plan and the Board members shall be indemnified by the Corporation against the reasonable expenses, including attorneys’ fees actually and necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan or any Option granted thereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by independent legal counsel selected by the Corporation) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such member acted in bad faith in the performance of his duties; provided that within 20 days after institution of any such action, suit or proceeding, the member shall in writing offer the Corporation the opportunity, at its own expense, to handle and defend the same.
25. Use of Proceeds .
     The proceeds from the sale of shares of Common Stock pursuant to Options granted under the Plan shall constitute general funds of the Corporation.
26. Amendment of the Plan .
     The Board may from time to time amend, modify, suspend or terminate the Plan; provided, however, that no such action shall be made without shareholder approval where such change would be required in order to comply with Rule 16b-3 or the Code.

-12-


 

27. Effective Date of Plan .
     The Plan shall become effective on the date it approved by the shareholders of the Corporation (the “Effective Date”).
28. Termination of the Plan .
     The Plan will expire ten (10) years after the Effective Date, solely with respect to the granting of Incentive Stock Options or such later date as may be permitted by the Code for Incentive Stock Options; provided, however, that the Plan shall terminate at such earlier time as the Board may determine. Any such termination, either partially or wholly, shall not affect any Awards then outstanding under the Plan.

-13-

Exhibit 10.2
PLEXUS CORP.
NON-QUALIFIED STOCK OPTION AGREEMENT
TO:    <<FIRST_NAME>> <<LAST_NAME>>
 
DATE:    <<OPTION DATE>>
     In order to provide additional incentive through stock ownership for certain directors, officers and key employees of Plexus Corp. (the “Corporation”) and its subsidiaries, you (the “Grantee”) are hereby granted a Non-Qualified Stock Option (“Option”) effective as of <<OPTION DATE>> (the “Grant Date”), to purchase <<TOTAL SHARES GRANTED>> shares of the Corporation’s Common Stock at a price per share of <<OPTION PRICE>>.
     This Option is subject to the terms and conditions set forth in this Agreement and in the Plexus Corp. 2008 Long-Term Incentive Plan (the “Plan”), the terms of which are incorporated herein by reference.
      [One of the following alternatives shall be designated. If no alternative is designated, Alternative 1 shall apply]:
o     Alternative 1: This Option shall become exercisable in accordance with the schedule set forth below:
         
Years After
Grant Date
  Percentage of Grant
Which May Be Exercised
 
       
Less than 1
    0 %
 
       
1 but less than 2
  Fifty percent (50%)
 
       
2 or more
  One hundred percent (100%)
o     Alternative 2: This Option shall become exercisable on the Grant Date.
o     Alternative 3: This Option shall become exercisable in accordance with the schedule established by the Committee at the time of grant and set forth below:
                                                                                                                                                                                                               .
     This Option will lapse after ten (10) years from the Grant Date and thus may not be exercised thereafter. No part of this Option is transferable or assignable, in whole or in part, unless otherwise provided for in the Plan.
     You may exercise this Option provided that it meets all vesting requirements, by logging on to www.etrade.com/stockplans or by calling E*Trade Executive Services at 800.775.2793. The website provides you with detailed instructions on how to exercise stock options as well as other relevant information pertaining to your grant. Keep in mind that if you are considered an “insider” you are subject to blackout restrictions which may prevent exercise during certain time periods referred to as the ‘blackout period”. If you are considered an “insider” you have been notified of the restrictions via email.

 


 

     If you received this Option because of your employment with the Corporation, this Option shall terminate on the date you cease to be employed by the Corporation or its subsidiaries, except that (i) during the ninety day period following the date of such termination of employment and if such termination is not for cause, you shall be entitled to exercise the Option granted hereunder to the extent such Option was exercisable on the date of the termination of your employment, and (ii) during the three-year period following the date of termination of employment due to death, permanent disability or retirement in accordance with normal Corporation retirement practices, as determined by the Committee in its sole discretion, you or your representative shall be entitled to exercise the Option granted hereunder to the extent such Option was exercisable on the date of the termination of your employment due to death, permanent disability or retirement (to the extent not previously exercised). Such ninety-day or three-year period shall not, however, extend the term of any Option beyond the date such Option would otherwise have lapsed.
     If you received this Option because of your service on the Board, this Option shall terminate on the date you cease to be a director, except that you shall be entitled to exercise the Option granted hereunder to the extent such Option was exercisable on the date of your termination of service until the earlier of (a) ten (10) years from the Grant Date, or (b) two (2) years from the date you cease to be a director.
     Prior to the exercise of an Option you should consult your tax advisor regarding the tax consequences thereof. No shares shall be issued upon exercise of an Option until withholding taxes, if any and if applicable, and any other withholding obligation, if any and if applicable, have been satisfied (as applicable). The Committee may provide that, if and to the extent withholding of any federal, state or local tax is required in connection with the exercise of an Option, the Grantee may elect, at such time and in such manner as the Committee may prescribe, to satisfy this withholding requirement, in whole or in part, by having the Corporation withhold shares having a Fair Market Value on the date the tax is to be determined equal to the minimum marginal total tax which could be imposed on the transaction.
     Under applicable securities laws, you may not be able to sell any shares for a period of time after your purchase, and you must comply with the Company’s Insider Trading Restrictions and Policies. The Corporation’s counsel should be consulted on your ability to sell your shares under the 1934 Act.
     The Plan provides that no Option may be exercised unless the Plan is in full compliance with all laws and regulations applicable thereto.
     No amendment, modification or waiver of this Agreement, in whole or in part, shall be binding unless consented to in writing by the Corporation and no amendment may cause any Grantee to be unfavorably affected with respect to any Option already granted hereunder.

 


 

     Neither the establishment of, nor the awarding of Options under this Plan shall be construed to create a contract of employment or service between any Grantee and the Corporation or its subsidiaries; nor does it give any Grantee the right to continue in the employment or service of the Corporation or its subsidiaries or limit in any way the right of the Corporation or its subsidiaries to discharge any Grantee at any time and without notice, with or without cause, or to any benefits not specifically provided by this Plan, or in any manner modify the Corporation’s right to establish, modify, amend or terminate any profit sharing, retirement or other benefit plans.
     To accept this grant, agreement and other linked materials please logon with your user name and password to www.etrade.com/stockplans and select the Stock Options page. This grant will be listed at the bottom of all prior grants and will be labeled in the status column as “Requires Acceptance”. Clicking on this link will take you to the Grant Acceptance page which will allow you to view and print (recommended) all applicable documents related to this grant. To accept the grant and all applicable documents you will type in your password and click accept. By accepting this grant online you acknowledge and accept this grant and the terms and conditions. You also acknowledge receipt of this Stock Option Agreement, a copy of the 2008 Long-Term Incentive Plan, and a copy of the Insider Trading Restrictions and Policies. If this grant is not accepted online within thirty (30) days from the grant date of this Agreement, this Option will be deemed refused and may be withdrawn.
         
  PLEXUS CORP.
 
 
  /s/ Angelo M. Ninivaggi    
  By: Angelo M. Ninivaggi, Secretary   
     
 

 

Exhibit 10.3
PLEXUS CORP. 2008 LONG-TERM INCENTIVE PLAN
UNRESTRICTED STOCK AWARD
TO:
DATE:
     I am pleased to notify you that, as a non-employee member of the Board of Directors of Plexus Corp. (the “ Corporation ”), you have been awarded under the Plexus Corp. 2008 Long-Term Incentive Plan (the “ LTIP ”) an Unrestricted Stock Award of                       shares of the Corporation’s common stock, $.01 par value (the “ Award Shares ”). Except as provided in the next paragraph, the Award Shares will be transferred to you on                      .
     If you made a valid, timely election (available for 2011 and later years only) to defer receipt of the Award Shares, then your deferral election and the terms of the Plexus Corp. Non-Employee Directors Deferred Compensation Plan will determine when the Award Shares are transferred to you (prior to that transfer your award will be represented by Deferred Stock Units as defined in the LTIP).
     As a reminder, applicable securities laws may restrict your ability to sell the shares you receive under this award. You must comply with the Corporation’s Insider Trading Restrictions and Policies, a copy of which is included with this letter. The Corporation’s counsel should be consulted on your ability to sell your shares under the 1934 Act.
     As an additional reminder, the fair market value of the shares on the transfer date will be includible in your gross income (as ordinary income) and will be reported on IRS Form 1099.
         
  PLEXUS CORP.
 
 
  By:   Angelo M. Ninivaggi, Secretary    
       
       
 

Exhibit 10.4
PLEXUS CORP.
NON-EMPLOYEE DIRECTORS DEFERRED COMPENSATION PLAN

 


 

Article 1. Establishment, Objectives and Duration
      1.1 Plan Objectives. Plexus Corp., a Wisconsin corporation (the “Corporation”), hereby adopts the deferred compensation plan for non-employee directors known as the “Non-Employee Directors Deferred Compensation Plan” (hereinafter referred to as the “Plan”), as set forth in this document. The objectives of the Plan are to give the Corporation an advantage in attracting and retaining Non-Employee Directors and to link the interests of Non-Employee Directors to those of the Corporation’s stockholders.
      1.2 Duration of the Plan. The Plan commenced on December 23, 2009 (the “Effective Date”) and will remain in effect until the Board of Directors terminates it pursuant to Section 6.1.
Article 2. Definitions
     The following defined terms have the meanings set forth below:
      “Affiliate” means any person that, directly or indirectly, is in control of, is controlled by, or is under common control with, the Corporation.
      “Annual Retainer” means the fee paid to the Non-Employee Director by the Corporation as compensation for service as a member of the Board for one year.
      “Beneficiary” means the person entitled under Section 5.5 to receive payment of the balances remaining in a Non-Employee Director’s Deferral Account in case the Non-Employee Director dies before the entire balance in that account has been paid.
      “Board” or “Board of Directors” means the Board of Directors of the Corporation.
      “Change in Control” has the meaning given to such term in the LTIP, but only to the extent such event is also a change in control event for purposes of Code Section 409A.
      “Code” means the Internal Revenue Code of 1986, as amended from time to time, or any successor to it.
      “Corporation” means Plexus Corp., a Wisconsin corporation, and any successor thereto as provided in Section 6.3.
      “Deferral Election” has the meaning ascribed to it in Section 5.1.
      “Deferral Account” means the account described in Section 5.3, to which a Non-Employee Director’s deferrals are credited.
      “Director ” means any individual who is a member of the Board of Directors.
      “Effective Date” has the meaning ascribed to it in Section 1.2.

2


 

      “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor to it.
      “Installment Payment” has the meaning ascribed to it in Section 5.4.
      “LTIP” means the Plexus Corp. 2008 Long-Term Incentive Plan or any successor plan.
      “Meeting Attendance Fee” means the paid to the Non-Employee Director by the Corporation as compensation for attendance at a meeting of the Board or a meeting of a committee of the Board, whether in-person or not.
      “Non-Employee Director” means a Director who, at the time in question, is not an employee of the Corporation or any of its Affiliates.
      “Plan” has the meaning ascribed to it in Section 1.1.
      “Plan Year” means the annual term of the Board of Directors commencing on the date the Board is elected by the shareholders of the Corporation.
      “Redeferral Election” means a change in time or form of payment election described in Section 1.409A-2(b).
      “Separation from Service” or “Separate from Service” means a separation from service within the meaning of Code Section 409A and the regulations thereunder.
      “Stock Awards” means stock-based awards made under the LTIP.
      “Termination Date” means the date on which a Non-Employee Director has a Separation from Service.
Article 3. Administration
      3.1 The Board of Directors. The Plan will be administered by the Board of Directors. The Board of Directors will act by a majority of its members at the time in office and eligible to vote on any particular matter, and may act either by a vote at a meeting or in writing without a meeting.
      3.2 Authority of the Board of Directors. Except as limited by law and subject to the provisions herein, the Board of Directors has full power to: construe and interpret the Plan and any agreement or instrument entered into under the Plan; establish, amend or waive rules and regulations for the Plan’s administration; and amend the terms and conditions of the Plan. Further, the Board of Directors will make all other determinations which may be necessary or advisable for the administration of the Plan. As permitted by law and consistent with Section 3.1, the Board of Directors may delegate some or all of its authority under this Plan.

3


 

      3.3 Decisions Binding. All determinations and decisions made by the Board of Directors pursuant to the provisions of the Plan will be final, conclusive and binding on all persons, including the Corporation, its stockholders, all Affiliates, Non-Employee Directors and their estates and beneficiaries.
Article 4. Eligibility
    Each Non-Employee Director will be eligible to participate in the Plan.
Article 5. Deferral
      5.1 Deferral Election. Any Non-Employee Director may elect, in accordance with such rules as the Board may determine, to defer all or a portion of the Annual Retainer, Meeting Attendance Fees and Stock Awards with respect to compensation for services performed in a Plan Year by filing with the Secretary of the Corporation a written notice to that effect on the Deferral Election Form attached hereto as Exhibit A (a “Deferral Election”) or on such other form as the Board shall specify. Such election must be filed before the first day of the calendar year in which the Plan Year commences, or such later date as the Board permits, consistent with the requirements of Code Section 409A and the regulations thereunder. Except as otherwise provided in Section 5.2, a Deferral Election may not be revoked or modified. A Non-Employee Director may make a new Deferral Election for each Plan Year.
      5.2 Redeferral Election. The Board of Directors may, in its discretion, permit Non-Employee Directors to make Redeferral Elections. Any such Redeferral Elections shall be made consistent with the requirements of Code Section 409A and the regulations thereunder.
      5.3 Deferral Account. All amounts deferred pursuant to a Deferral Election will be credited by the Corporation to a Deferral Account for the Non-Employee Director. The Deferred Account shall consist of a Deferred Cash Account, to which cash deferrals shall be credited, and a Deferred Stock Account, to which stock units (each corresponding to a share of the Corporation’s common stock) shall be credited. In the event that dividends are paid on shares of common stock, the amount of dividends that would have been paid with respect to a number of shares equal to the number of stock units in a Non-Employee Director’s Deferred Stock Account shall be credited to his or her Deferred Cash Account. Amounts in the Deferred Cash Account shall be credited with interest, compounded monthly, from the date the compensation would otherwise have been payable to the Non-Employee Director until the amount credited to the Deferral Account is paid to him or her. The rate of interest will be the prime rate of interest as reported by the Midwest edition of the Wall Street Journal for the second business day of each quarter on an annual basis. Stock-based awards will be credited to a Non-Employee Director’s Deferral Account in units
      5.4 Distributions. The value of a Non-Employee Director’s Deferral Account with respect to a Plan Year will be distributed, or will begin to be distributed, to him or her or, in the event of his or her death, to his or her Beneficiary, within 10 days following the earliest of:

4


 

  (a)   the date specified by the Non-Employee Director in his or her Deferral Election for such Plan Year;
 
  (b)   the Non-Employee Director’s Termination Date; and
 
  (c)   the date on which a Change in Control occurs.
     Distribution from a Non-Employee Director’s Deferral Account will be paid to him or her in a lump sum or in installments in accordance with his or her Deferral Election for such Plan Year. If a Non-Employee Director fails to elect a payout form, his or her distribution will be paid in a single lump sum.
     If a Non-Employee Director elects to receive payment from his or her Deferral Account in installments, the payment period for the installments will not exceed ten years. The amount of each installment payment will equal the product of (a) the balance in the Non-Employee Director’s Deferral Account allocable to the Plan Year on the date the payment is made multiplied by (b) a fraction, the numerator of which is one and the denominator of which is the number of unpaid remaining installments. The balance will be appropriately reduced to reflect any Installment Payments already made hereunder. Notwithstanding the foregoing, in the event of a Change in Control, the balance remaining in a Non-Employee Director’s Deferral Account will be paid in a single lump sum payment within 10 days following the Change in Control.
     If a Non-Employee Director dies before he or she has received payment of all amounts due hereunder, the balance remaining in the Non-Employee Director’s Deferral Account will be distributed to his or her Beneficiary in a single lump sum payment within 90 days following the Non-Employee Director’s death.
     Notwithstanding anything to the contrary in this Section 5.4:
  (a)   To the extent necessary to avoid liability under Section 16(b) of the Exchange Act, the amount attributable to any stock units that will have been credited to the Non-Employee Director’s Deferral Account for a period of less than six months will be distributed, or commence to be distributed, within 10 days following the expiration of such six month period.
 
  (b)   If the Non-Employee Director is a “specified employee” (within the meaning of Code Section 409A(a)(2)(B)), then notwithstanding any provision in the Plan to the contrary, payments triggered by the Non-Employee Director’s Termination Date will not be paid until six months after the Non-Employee Director’s Termination Date or until the Non-Employee Director’s earlier death. The foregoing six-month delay provision will not affect the timing of payments that would otherwise be paid more than six months after the Non-Employee Director’s Termination Date.

5


 

      5.5 Beneficiary. A Non-Employee Director may designate, on the Beneficiary Designation form attached hereto as Exhibit B, any person to whom payments are to be made if the Non-Employee Director dies before receiving payment of all amounts due hereunder. A Beneficiary Designation form becomes effective only after the signed form is filed with the Secretary of the Corporation while the Non-Employee Director is alive, and will cancel any prior Beneficiary Designation form. If the Non-Employee Director fails to designate a Beneficiary or if all designated Beneficiaries predecease the Non-Employee Director, the Non-Employee Director’s Beneficiary will be his or her estate.
Article 6. Miscellaneous
      6.1 Modification and Termination. The Board may at any time and from time to time, alter, amend, modify or terminate the Plan in whole or in part.
      6.2 Indemnification. Each person who is or has been a member of the Board will be indemnified and held harmless by the Corporation against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by that person in connection with or resulting from any claim, action, suit, or proceeding to which that person may be a party or in which that person may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by that person in a settlement approved by the Corporation, or paid by that person in satisfaction of any judgment in any such action, suit, or proceeding against that person, provided he or she gives the Corporation an opportunity, at its own expense, to handle and defend the action, suit or proceeding before that person undertakes to handle and defend it. The foregoing right of indemnification will not be exclusive of any other rights of indemnification to which an individual may be entitled under the Corporation’s Certificate of Incorporation or By-Laws, as a matter of law, or otherwise, or any power that the Corporation may have to indemnify him or her or hold him or her harmless.
      6.3 Successors. All obligations of the Corporation under the Plan with respect to a given Plan Year will be binding on any successor to the Corporation, whether the existence of the successor is the result of a direct or indirect purchase of all or substantially all of the business and/or assets of the Corporation, or a merger, consolidation, or otherwise.
      6.4 Reservation of Rights. Nothing in this Plan or in any deferral election form provided by the Corporation will be construed to limit in any way the Board’s right to remove a Non-Employee Director from the Board of Directors.
Article 7 Legal Construction
      7.1 Gender and Number. Except where otherwise indicated by the context, any masculine term used herein will also include the feminine; the plural will include the singular and the singular will include the plural.

6


 

      7.2 Severability. If any provision of the Plan is held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provision had not been included.
      7.3 Requirements of Law. The issuance of payments under the Plan will be subject to all applicable laws, rules, and regulations, and to any approvals required by any governmental agencies or national securities exchanges.
      7.4 Securities Law and Tax Law Compliance.
  (a)   Insider Trading. To the extent any provision of the Plan or action by the Board would subject any Non-Employee Director to liability under Section 16(b) of the Exchange Act, it will be deemed null and void, to the extent permitted by law and deemed advisable by the Board.
 
  (b)   Section 409A. This Plan is intended to comply with Code Section 409A and the regulations thereunder, and will be administered and interpreted in accordance with such intent. If the Corporation determines that any provision of the Plan is or might be inconsistent with the requirements of Code Section 409A, it will attempt in good faith to make such changes to the Plan as may be necessary or appropriate to avoiding a Non-Employee Director’s becoming subject to adverse tax consequences under Code Section 409A. No provision of the Plan will be interpreted to transfer any liability for a failure to comply with Code Section 409A from a Non-Employee Director or any other individual to the Corporation.
      7.5 Unfunded Status of the Plan. The Plan is intended to constitute an “unfunded” plan. With respect to any payments not yet made to a Non-Employee Director by the Corporation, nothing contained herein will give any rights to a Non-Employee Director that are greater than those of a general creditor of the Corporation.
      7.6 Governing Law. The Plan will be construed in accordance with and governed by the laws of the State of Wisconsin, determined without regard to its conflict of law rules.
      7.7 Nontransferability. A Non-Employee Director’s Deferral Account may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, or pursuant to a domestic relations order (as defined in Code Section 414(p)). All rights with respect to the Deferral Account will be available during the Non-Employee Director’s lifetime only to the Non-Employee Director or the Non-Employee Director’s guardian or legal representative. The Board of Directors may, in its discretion, require a Non-Employee Director’s guardian or legal representative to supply it with evidence the Board of Directors deems necessary to establish the authority of the guardian or legal representative to act on behalf of the Non-Employee Director.

7


 

EXHIBIT A
PLEXUS CORP.
NON-EMPLOYEE DIRECTORS DEFERRED COMPENSATION PLAN
BOARD OF DIRECTORS [INSERT YEAR] STOCK AWARD
DEFERRAL ELECTION
Please return to Plexus Corp., 55 Jewelers Park Drive, Neenah, WI 54956, so that it is received by Plexus on or before [INSERT DATE]. If no Deferral Election is received by that date, the stock award will be paid [DEFAULT PAYMENT TIMING].
          1. Deferral Election . In accordance with the terms of the Non-Employee Directors Deferred Compensation Plan (the “ Plan ”), I hereby elect to defer the following portion of any stock award, excluding any stock options, expected to be granted to me by Plexus Corp. (the “ Corporation ”) in [INSERT YEAR] (the “ [INSERT YEAR] Stock Award ”):
                           % (Enter any whole percentage less than or equal to 100%. This election does not apply to any portion of the award consisting of stock options.)
          2. Timing of Payout . I wish to receive payment of the portion of the [INSERT YEAR] Stock Award deferred pursuant to the election above (or, if applicable, the first installment of such amount) within 10 days following the earliest of:
  (a)   the date of my separation from service with the Corporation, and
 
  (b)   the date on which a Change in Control occurs, and
 
  (c)                                               (insert a date no earlier than [INSERT DATE] or insert “N/A”) .
          I understand that if I continue to provide services for the Corporation in another capacity after I cease to be a director, my distribution may be automatically postponed until I incur a separation from service, as determined under Section 409A of the Internal Revenue Code of 1986, as amended (the “ Code ”). For purposes of this election, a “Change in Control” means an event that constitutes a Change in Control as defined in the Plexus Corp. 2008 Long-Term Incentive Plan and that qualifies as a change in control event for purposes of Code Section 409A.

8


 

          3. Form of Payout . I hereby elect to receive payment of the portion of the [INSERT YEAR] Stock Award deferred pursuant to the election above in the following form (elect one) :
                         single lump sum payment, or
 
                         installments over       years (not to exceed 10 years) payable (elect one) :
                         quarterly,
 
                         semi-annually, or
 
                         annually.
          I understand that my election is subject to the terms of the Plan, and that except as otherwise provided in the Plan my election is irrevocable. I may change the date listed in 2(c), above, only by making an irrevocable election 12 months or more in advance of that date and only if I postpone the date for at least five years.
          Moreover, I understand that I may change the form of payout selected above, but that such a change would not become effective for 12 months. Any such election to change the form of payout must postpone my payment until at least five years after it would otherwise have been paid (even if the payment trigger is a separation from service or a change in control).
          IN WITNESS WHEREOF, the Director has duly executed this Stock Award Deferral Election as of the date first written above.
         
     
Director’s Signature     
     
     
Director’s Name (please print)      
     

9


 

         
EXHIBIT B
PLEXUS CORP.
NON-EMPLOYEE DIRECTORS DEFERRED COMPENSATION PLAN
BENEFICIARY DESIGNATION
          I hereby designate the following person or persons as primary beneficiary in the case of my death before I receive full payment of any stock awards granted to me by Plexus Corp. (the “ Corporation ”) that have been deferred under the Non-Employee Directors Deferred Compensation Plan. This designation does not apply to any stock options granted to me by the Corporation.
  1.   Primary Beneficiary .
  Name:     
 
 
  Relationship:     
 
 
  Address:      
 
 
 
     
 
 
     
 
 
  Percent:     
 
  Name:      
 
 
  Relationship:     
 
 
  Address:     
 
 
 
     
 
 
     
 
  Percent:     
 
  Name:     
 
 
  Relationship:     
 
 
  Address:     
 
 
       
 
 
 
     
 
  Percent:     
 

10


 

          2.  Secondary Beneficiary . I hereby designate the following person or persons as secondary beneficiary for my stock awards described above, in the case that no primary beneficiary survives me:
  Name:      
 
 
  Relationship:     
 
 
  Address:     
 
 
       
 
 
       
 
 
  Percent:     
 
  Name:     
 
 
  Relationship:     
 
 
  Address:     
 
 
       
 
 
       
 
 
  Percent:     
 
  Name:     
 
 
  Relationship:     
 
 
  Address:     
 
 
       
 
 
       
 
 
  Percent:     
 
          I understand that my election is subject to the terms of the Plan, and that except as otherwise provided in the Plan my election is irrevocable.
          IN WITNESS WHEREOF, the Director has duly executed this beneficiary designation as of the date first written above.
         
     
Director’s Signature     
     
 
     
Director’s Name (please print)      
     
 

11

Exhibit 31.1
CERTIFICATION
I, Dean A. Foate, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the quarter ended January 2, 2010 of Plexus Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-(f)) for the registrant and have:
  a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
  a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
  b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 4, 2010
         
     
  /s/ Dean A. Foate    
  Dean A. Foate    
  President and Chief Executive Officer   

         
Exhibit 31.2
CERTIFICATION
I, Ginger M. Jones, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the quarter ended January 2, 2010 of Plexus Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-(f)) for the registrant and have:
  a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
  a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
  b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 4, 2010
         
     
  /s/ Ginger M. Jones    
  Ginger M. Jones   
  Chief Financial Officer   

         
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     In connection with the Quarterly Report of Plexus Corp. (the “Company”) on Form 10-Q for the quarterly period ended January 2, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dean A. Foate, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
  (1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  (2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Dean A. Foate           
Dean A. Foate
Chief Executive Officer
February 4, 2010
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Plexus Corp. and will be retained by Plexus Corp. and furnished to the Securities and Exchange Commission or its staff upon request.

Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     In connection with the Quarterly Report of Plexus Corp. (the “Company”) on Form 10-Q for the quarterly period ended January 2, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ginger M. Jones, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
  (1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  (2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Ginger M. Jones           
Ginger M. Jones
Chief Financial Officer 
February 4, 2010
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Plexus Corp. and will be retained by Plexus Corp. and furnished to the Securities and Exchange Commission or its staff upon request.